<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">55729</article-id><article-id pub-id-type="doi">10.7554/eLife.55729</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Neuroscience</subject></subj-group></article-categories><title-group><article-title>Axonal mechanisms mediating γ-aminobutyric acid receptor type A (GABA-A) inhibition of striatal dopamine release</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-62330"><name><surname>Kramer</surname><given-names>Paul F</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0095-3712</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174284"><name><surname>Twedell</surname><given-names>Emily L</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174285"><name><surname>Shin</surname><given-names>Jung Hoon</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-9892-1275</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-174286"><name><surname>Zhang</surname><given-names>Renshu</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-27728"><name><surname>Khaliq</surname><given-names>Zayd M</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-1445-1457</contrib-id><email>zayd.khaliq@nih.gov</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Cellular Neurophysiology Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution>Laboratory on Neurobiology of Compulsive Behaviors, National Institute of Alcohol Abuse and Alcoholism, National Institutes of Health</institution><addr-line><named-content content-type="city">Bethesda</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Overstreet-Wadiche</surname><given-names>Linda</given-names></name><role>Reviewing Editor</role><aff><institution>University of Alabama at Birmingham</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Huguenard</surname><given-names>John</given-names></name><role>Senior Editor</role><aff><institution>Stanford University School of Medicine</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>01</day><month>09</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e55729</elocation-id><history><date date-type="received" iso-8601-date="2020-02-03"><day>03</day><month>02</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-08-15"><day>15</day><month>08</month><year>2020</year></date></history><permissions><ali:free_to_read/><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><ali:license_ref>http://creativecommons.org/publicdomain/zero/1.0/</ali:license_ref><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0 public domain dedication</ext-link>.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-55729-v1.pdf"/><abstract><p>Axons of dopaminergic neurons innervate the striatum where they contribute to movement and reinforcement learning. Past work has shown that striatal GABA tonically inhibits dopamine release, but whether GABA-A receptors directly modulate transmission or act indirectly through circuit elements is unresolved. Here, we use whole-cell and perforated-patch recordings to test for GABA-A receptors on the main dopaminergic neuron axons and branching processes within the striatum of adult mice. Application of GABA depolarized axons, but also decreased the amplitude of axonal spikes, limited propagation and reduced striatal dopamine release. The mechanism of inhibition involved sodium channel inactivation and shunting. Lastly, we show the positive allosteric modulator diazepam enhanced GABA-A currents on dopaminergic axons and directly inhibited release, but also likely acts by reducing excitation from cholinergic interneurons. Thus, we reveal the mechanisms of GABA-A receptor modulation of dopamine release and provide new insights into the actions of benzodiazepines within the striatum.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>dopamine</kwd><kwd>axonal physiology</kwd><kwd>GABA-A</kwd><kwd>benzodiazepines</kwd><kwd>diazepam</kwd><kwd>striatum</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Mouse</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>NS003134</award-id><principal-award-recipient><name><surname>Khaliq</surname><given-names>Zayd M</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><award-id>ZIA-AA000421</award-id><principal-award-recipient><name><surname>Shin</surname><given-names>Jung Hoon</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Kramer</surname><given-names>Paul F</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>GABA-A receptors on dopamine neuron axons not only depolarize the membrane but also limit action potential propagation, an effect potentiated by positive allosteric modulators of GABA-A receptors like diazepam (Valium).</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Axons of midbrain dopaminergic neurons are highly complex structures that transmit reward, associative-learning, and motor control signals to terminal boutons via action potentials that trigger the release of dopamine (<xref ref-type="bibr" rid="bib3">Aransay et al., 2015</xref>; <xref ref-type="bibr" rid="bib48">Matsuda et al., 2009</xref>; <xref ref-type="bibr" rid="bib75">Sulzer et al., 2016</xref>). In addition to spike transmission, dopamine neuron axons within the striatum integrate local information. For example, striatal cholinergic interneurons modulate dopamine release through activation of nicotinic receptors on dopamine neuron axons (<xref ref-type="bibr" rid="bib62">Rice and Cragg, 2004</xref>; <xref ref-type="bibr" rid="bib89">Zhang and Sulzer, 2004</xref>) and synchronous activation of cholinergic interneurons can directly trigger dopamine release (<xref ref-type="bibr" rid="bib14">Cachope et al., 2012</xref>; <xref ref-type="bibr" rid="bib80">Threlfell et al., 2012</xref>). Similarly, other receptors have been shown to modulate dopamine release such as dopamine D2 (<xref ref-type="bibr" rid="bib23">Ford, 2014</xref>), GABA-B (<xref ref-type="bibr" rid="bib56">Pitman et al., 2014</xref>), metabotropic glutamate (<xref ref-type="bibr" rid="bib88">Zhang and Sulzer, 2003</xref>), and muscarinic receptors (<xref ref-type="bibr" rid="bib69">Shin et al., 2015</xref>). These data show that direct modulation of the axon presents a powerful means of controlling striatal dopaminergic signaling in a manner that is independent of somatic processing, suggesting a degree of functional segregation between these two cellular compartments (<xref ref-type="bibr" rid="bib15">Cachope and Cheer, 2014</xref>; <xref ref-type="bibr" rid="bib31">Hamid et al., 2016</xref>; <xref ref-type="bibr" rid="bib50">Mohebi et al., 2019</xref>). Understanding the mechanisms that govern local control of dopamine release within the striatum will require better mechanistic knowledge of how presynaptic receptors shape axonal excitability.</p><p>GABA has long been known to modulate striatal dopamine release (<xref ref-type="bibr" rid="bib25">Giorguieff et al., 1978</xref>; <xref ref-type="bibr" rid="bib60">Reimann et al., 1982</xref>; <xref ref-type="bibr" rid="bib73">Starr, 1978</xref>) but the specific contribution of GABA-A receptors (GABA-ARs) to this process is unclear. Fast-scanning cyclic voltammetry (FSCV) studies found that antagonists of GABA-ARs reduce dopamine release through an indirect mechanism involving H<sub>2</sub>O<sub>2</sub> produced downstream of AMPA receptors, suggesting that GABA-ARs enhance dopamine release (<xref ref-type="bibr" rid="bib5">Avshalumov et al., 2003</xref>; <xref ref-type="bibr" rid="bib71">Sidló et al., 2008</xref>). By contrast, in vivo microdialysis studies have found that striatal infusions of GABA-AR antagonists lead to an increase in dopamine release, suggesting that striatal GABA-ARs inhibit dopamine release (<xref ref-type="bibr" rid="bib28">Gruen et al., 1992</xref>; <xref ref-type="bibr" rid="bib72">Smolders et al., 1995</xref>). Consistent with this finding, a recent FSCV study showed that GABA-AR activation leads to inhibition of dopamine release, but argued that the effect was indirect through GABA-B receptors located on dopamine neuron axons (<xref ref-type="bibr" rid="bib13">Brodnik et al., 2019</xref>). A separate study showed that GABA-AR activation inhibits dopamine release in the absence of nicotinic receptor activation which led to the proposal that GABA-A receptors may be present on the terminals of dopaminergic neurons (<xref ref-type="bibr" rid="bib45">Lopes et al., 2019</xref>). However, definitive evidence for this proposal is lacking.</p><p>Benzodiazepines are positive allosteric modulators of GABA-ARs that are increasingly prescribed in the United States (<xref ref-type="bibr" rid="bib7">Bachhuber et al., 2016</xref>). These drugs have demonstrated misuse liability that in rare cases leads to a substance use disorder (<xref ref-type="bibr" rid="bib9">Blanco et al., 2018</xref>). The mechanism of benzodiazepine reward is thought mainly to involve disinhibition of somatic firing (<xref ref-type="bibr" rid="bib78">Tan et al., 2010</xref>). Similar to many drugs of abuse, systemically-applied benzodiazepines result in acute glutamate receptor plasticity in dopamine neurons (<xref ref-type="bibr" rid="bib34">Heikkinen et al., 2009</xref>; <xref ref-type="bibr" rid="bib40">Kauer and Malenka, 2007</xref>) and increase the frequency of individual dopamine release events in the striatum (<xref ref-type="bibr" rid="bib67">Schelp et al., 2018</xref>). Unlike other drugs of abuse, however, benzodiazepines have been shown to decrease the amplitude of striatal dopamine release (<xref ref-type="bibr" rid="bib28">Gruen et al., 1992</xref>; <xref ref-type="bibr" rid="bib67">Schelp et al., 2018</xref>). These opposing effects suggest that benzodiazepines can differentially influence activity in the soma and release from axon terminals. To disentangle these conflicting results, we made direct axonal recordings from main axons and performed perforated-patch recordings of subthreshold voltage from branching processes of dopaminergic neuron axons within the striatum. In addition, we used calcium imaging, fast scanning cyclic voltammetry, and fluorescent sensor imaging of dopamine release. Our experimental findings provide mechanistic understanding of how axonal GABA-A receptors control the excitability and transmitter release from dopamine neuron axons.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Characteristics of action potentials in dopaminergic neuron axons – main axons and striatal terminal axons</title><p>Dopamine neurons of substantia nigra <italic>pars compacta</italic> form thin, unmyelinated axons that project to the dorsal striatum through the medial fiber bundle (MFB). To examine action potential firing in the main unbranching axon from adult mice, we used a horizontal brain slice preparation which preserved the connection between the cell bodies of SNc dopaminergic neurons and their MFB projecting axons. Dopaminergic neuron axons within the MFB were identified using the fluorescent marker proteins GFP or td-Tomato from TH-GFP or DAT-CRE x Ai9 mice, respectively. Using these optimized brain slices in combination with marker mice enabled us to record propagating action potentials from the main axon at distances of greater than two millimeters from the soma (<xref ref-type="fig" rid="fig1">Figure 1A</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Whole-cell and perforated-patch recordings from dopamine neuron axons.</title><p>(<bold>A</bold>) Main axon recorded in whole-cell mode with a connected soma (filled with neurobiotin, imaged with streptavidin-Cy5, slice cleared with CUBIC, <italic>red</italic>); GFP driven by the TH promoter (<italic>green</italic>). (<bold>B</bold>) Trace of spontaneous action potentials recorded from a dopaminergic axon (<italic>left</italic>). Firing rate from somatic (<italic>n</italic> = 10) and axonal recordings (<italic>n</italic> = 41; p=0.298) (<italic>right</italic>). (<bold>C</bold>) Overlay of an axonal and somatic spike (<italic>left</italic>). Phase plot for a somatic and axonal action potential (<italic>right</italic>). (<bold>D</bold>) Half-peak widths from somatic (<italic>n</italic> = 10) and axonal (<italic>n</italic> = 27) APs (**p=0.008). (<bold>E</bold>) AP thresholds recorded from soma (<italic>n</italic> = 10) and axons (<italic>n</italic> = 26)(****p&lt;0.0001). (<bold>F</bold>) Example traces of interspike voltage from obtained from axonal (<italic>blue</italic>) and somatic (<italic>gray</italic>) recordings. (<bold>G</bold>) Slope of interspike voltage plotted against recording distance between axonal recording site (<italic>blue</italic>) and soma (<italic>gray</italic>). (<bold>H</bold>) Post-hoc reconstruction of a patched striatal axon. (<bold>I</bold>) Trace of subthreshold depolarization (<italic>left</italic>) and axonal AP (<italic>right</italic>) evoked by 250 pA and 275 pA current injection. (<bold>J</bold>) Input resistance values for main axon (<italic>n</italic> = 28) and striatal axons (<italic>n</italic> = 74) APs (****p&lt;0.0001). (<bold>K</bold>) Comparison of the mean interspike voltage between soma (<italic>n</italic> = 10) main axon (<italic>n</italic> = 21) and striatal axon, which was measured as the average resting membrane potential (<italic>n</italic> = 74) (*p=0.032; ***p=0.0007; ns p=0.87).</p><p> <supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>Raw values used for plots in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55729-fig1-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig1-v1.tif"/></fig><media id="fig1video1" mime-subtype="mp4" mimetype="video" xlink:href="elife-55729-fig1-video1.mp4"><label>Figure 1—video 1.</label><caption><title>Animated rotating movie of a striatal filled axon.</title><p>Reconstructed in Neurolucida.</p></caption></media></fig-group><p>To examine the characteristics of axonal action potentials, we made whole-cell recordings from the cut ends of axons (blebs) located on the surface of the slice (<xref ref-type="bibr" rid="bib38">Hu and Shu, 2012</xref>; <xref ref-type="bibr" rid="bib36">Hu et al., 2009</xref>; <xref ref-type="bibr" rid="bib70">Shu et al., 2007</xref>). We found that many axons exhibited spontaneous firing activity with median spontaneous rates that were nearly identical to somatic pacemaker rates (<xref ref-type="fig" rid="fig1">Figure 1B</xref>; axon: <inline-formula><mml:math id="inf1"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 3.3 Hz, n=41; soma: <inline-formula><mml:math id="inf2"><mml:mover accent="true"><mml:mrow><mml:mi mathvariant="normal">x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 2.75 Hz, n=10; Mann-Whitney U test, <italic>U</italic>=161, p=0.298), consistent with the slow, rhythmic firing associated with dopaminergic neurons (<xref ref-type="bibr" rid="bib27">Grace and Bunney, 1984</xref>). Axonal action potentials had narrower half-widths (<xref ref-type="fig" rid="fig1">Figure 1C and D</xref>; axon: <inline-formula><mml:math id="inf3"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 0.89 ms n=27, soma: <inline-formula><mml:math id="inf4"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 1.24 ms n=10; Mann-Whitney <italic>U</italic>=59, p=0.008 two-tailed) and a more hyperpolarized threshold relative to somatic spikes (<xref ref-type="fig" rid="fig1">Figure 1E</xref>; axon: <inline-formula><mml:math id="inf5"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = -56 mV, n=26; soma: <inline-formula><mml:math id="inf6"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = -41.7 mV n=10; <italic>U</italic>=9, p&lt;0.0001).</p><p>In the axon, the voltage trajectory between action potentials was shallow in slope (avg. dV/dt at middle 50% of the interspike interval, axon: <inline-formula><mml:math id="inf7"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 9.24 mV/s, n=27), reaching a minimum at the spike trough with little depolarization before reaching threshold. By contrast, the somatic interspike voltage exhibited a significantly greater slope on average (<xref ref-type="fig" rid="fig1">Figure 1F</xref>; avg. dV/dt, soma: <inline-formula><mml:math id="inf8"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 49.9 mV/s n=10; <italic>U</italic>=22, p&lt;0.0001), similar to previously reported values (<xref ref-type="bibr" rid="bib41">Khaliq and Bean, 2008</xref>). A plot of the slope of the interspike voltage against the axonal recording distance followed a roughly exponential relationship with the interspike slope, such that it becomes more shallow with increasing recording distance (<xref ref-type="fig" rid="fig1">Figure 1G</xref>; single exponential fit, length constant, λ=211 µm, n=27; R<sup>2</sup>=0.70; data were fit with a single exponential significantly better than with a line: F(1,24)=22.1, p&lt;0.0001). Axonal recordings at distances greater than two length constants from the soma (&gt; 422 µm) exhibited little sub-threshold depolarization between action potentials (<inline-formula><mml:math id="inf9"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula>=7.3 mV/s, n=13). In sum, action potentials recorded in the main axons of dopaminergic neurons are narrow, with voltage thresholds that are negative relative to somatic spikes.</p><p>Within the dorsal striatum the axons of dopaminergic neurons branch extensively while progressively decreasing in diameter (<xref ref-type="bibr" rid="bib48">Matsuda et al., 2009</xref>), which raises the question of how the properties of striatal terminal axons compare to those of the main axon. Using perforated-patch recordings to record from axon blebs, we found that terminal axons have a higher input resistance (<xref ref-type="fig" rid="fig1">Figure 1J</xref>; <inline-formula><mml:math id="inf10"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 1.83 GΩ, n=74) than the main axon (<inline-formula><mml:math id="inf11"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = 599 MΩ, n=28, <italic>U</italic>=254, p&lt;0.0001 two-tailed). The interspike membrane potential in the striatal dopamine neuron axon was hyperpolarized relative to the main axon, but both axonal compartments were more hyperpolarized relative to the average interspike voltage in the soma (<xref ref-type="fig" rid="fig1">Figure 1K</xref>; terminal axon: <inline-formula><mml:math id="inf12"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = -71 mV, main axon: <inline-formula><mml:math id="inf13"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula> = -68.9 mV, soma=-62.2 mV; Kruskal-Wallis H test χ<sup>2</sup>(2)=13.9, p=0.001; terminal vs. main p=0.87; terminal vs. soma, p=0.0007; soma vs. main, p=0.032). Together, these results show that the main and terminal axons of dopamine neurons are high input resistance compartments in which action potentials are evoked from relatively hyperpolarized interspike voltages.</p></sec><sec id="s2-2"><title>Identification of GABA-A receptor-mediated currents on dopaminergic neuron axons</title><p>Past work has shown that GABA-A receptors modulate dopamine release, but evidence that GABA-A receptors are located on dopaminergic neuron axons has been indirect. To test for a GABA-A receptor-mediated conductance in the axon, a second pipette was placed 30–60 µm from the axonal recording site on the main axon and GABA (300 µM-1 mM) was locally applied by a brief (80–300 ms) pressure ejection (<xref ref-type="fig" rid="fig2">Figure 2A,B</xref>). GABA puff resulted in depolarization of the axonal membrane potential by an average of 4.86 ± 0.66 mV (n = 9), which was completely blocked by the GABA-A antagonist picrotoxin (<xref ref-type="fig" rid="fig2">Figure 2C</xref>; 100 µM; t(8)=6.1, p=0.0003). To verify the direct nature of these currents, we tested the effect of increasing the concentration of intracellular chloride on the GABA-mediated depolarization. We found that filling axons with an internal solution containing high chloride resulted in GABA-mediated depolarizations that were 2.76-fold larger in amplitude (<xref ref-type="fig" rid="fig2">Figure 2D</xref>; low Cl<sup>-</sup>=4.74 ± 0.66 mV, high Cl<sup>-</sup>=13.1 ± 2.44 mV; t(13)=4.34, p=0.0008). These results provide direct evidence for the presence of functional GABA-A receptors on the axons dopaminergic neurons.</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>GABA-A receptors located on the axons of dopaminergic neuron are depolarizing.</title><p>(<bold>A</bold>) Schematic of experimental setup. (<bold>B</bold>) Example traces of pressure ejection of GABA onto the axon in control (<italic>black</italic>) and after application of picrotoxin (<italic>red</italic>). (<bold>C</bold>) Peak of amplitude of GABA-evoked depolarization in control and after picrotoxin (<italic>n</italic> = 9; ***p=0.0003). (<bold>D</bold>) Peak amplitude of GABA-evoked depolarization recorded with low (<italic>n</italic> = 5) or high (<italic>n</italic> = 10) chloride internal solutions (***p=0.0008). (<bold>E</bold>) Example traces overlaid from three different current injections. Timing of muscimol puff application indicated by <italic>arrow.</italic> (<bold>F</bold>) Peak of the muscimol-evoked depolarization plotted against the average interspike voltage. <italic>Fitted line</italic> was used to determine the reversal potential. (<bold>G</bold>) Paired values indicating mean interspike voltage (V<sub>interspike</sub>) and muscimol reversal potential (E<sub>musc</sub>) in individual axons (<italic>n</italic> = 15; ****p&lt;0.0001).</p><p> <supplementary-material id="fig2sdata1"><label>Figure 2—source data 1.</label><caption><title>Raw values used for plots in <xref ref-type="fig" rid="fig2">Figure 2</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55729-fig2-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig2-v1.tif"/></fig></sec><sec id="s2-3"><title>Axonal GABA-A receptors are depolarizing</title><p>The physiological function of GABA-A receptors is closely tied to its reversal potential, which has been shown to vary in axons across cell types from depolarizing (<xref ref-type="bibr" rid="bib58">Pugh and Jahr, 2011</xref>; <xref ref-type="bibr" rid="bib65">Ruiz et al., 2010</xref>; <xref ref-type="bibr" rid="bib77">Szabadics et al., 2006</xref>) to hyperpolarizing (<xref ref-type="bibr" rid="bib63">Rinetti-Vargas et al., 2017</xref>; <xref ref-type="bibr" rid="bib84">Xia et al., 2014</xref>). Therefore, we determined the GABA-A reversal potential in the main dopaminergic neuron axons using perforated-patch recordings in which the intracellular chloride concentration is preserved. While holding the axon at different membrane voltages with constant current, we applied single puffs of the GABA-A selective agonist muscimol and then measured the amplitude of the resulting muscimol-evoked membrane depolarization (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>). Our analysis showed that the average GABA-A reversal potential in dopamine neuron axons was −56.3 ± 2.38 mV (n = 15). Importantly, we found in all recorded axons that the reversal potential of axonal GABA-A current was always depolarized relative to the average interspike voltage of the axon (<xref ref-type="fig" rid="fig2">Figure 2E–G</xref>; V<sub>interspike=</sub>-68 ± 1.75 mV, p&lt;0.0001).</p></sec><sec id="s2-4"><title>GABA-A activation inhibits striatal dopamine release</title><p>Based on our finding that GABA-A receptors are depolarizing, we reasoned that activation of axonal GABA-receptors should enhance dopamine release. Therefore, we tested the effect of axonal GABA-A receptors on dopamine release using dLight 1.2 to image striatal dopamine. A stimulating electrode was placed at the caudal end of the striatum, and a burst of stimulations were elicited with a bipolar electrode (<xref ref-type="fig" rid="fig3">Figure 3A–C</xref>). Contrary to our expectation, we found that bath perfusion of muscimol (10 µM) depressed dopamine release by an average of 38.2 ± 6.6% (<xref ref-type="fig" rid="fig3">Figure 3C</xref>; RM 1-way ANOVA F(2, 26)=16.5; Bonferroni’s post-hoc t(8)=5.8, p=0.0008). While we observed a large inhibition in evoked dopamine release, we saw no change in the pre-stimulation (baseline) dLight signal following muscimol perfusion suggesting that muscimol does not alter background striatal dopamine (<xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>).</p><fig-group><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>GABA-A receptor mediated inhibition of striatal dopamine release.</title><p>(<bold>A–C</bold>) Imaging dopamine release in the dorsal medial striatum using dLight 1.2. (<bold>A</bold>) Experimental setup diagram. (<bold>B</bold>) Example traces of bulk dopamine release following electrical stimulation in control (black) and during muscimol bath application (green). (<bold>C</bold>) Group data showing the time course of muscimol application on dopamine release peak amplitude measured distal to the site of stimulation (average 1054 µm, <italic>n</italic> = 9; p=0.0008). (<bold>D–F</bold>) Voltammetry experiments using opsin-evoked dopamine release (DAT-Cre injected with CoChR in SNc). (<bold>D</bold>) Example voltammetry signal of dopamine in control (<italic>black</italic>) and during muscimol puff (<italic>green</italic>). <italic>Inset:</italic> example current-voltage plot of FSCV signal. (<bold>E</bold>) Time course of opsin-evoked dopamine release in an example experiment. (<bold>F</bold>) Summary data showing the main effect of muscimol puff on dopamine release measured with voltammetry. <italic>Closed symbols</italic> indicate individual experiments and <italic>open symbols</italic> indicate averaged data (p=0.004; <italic>n</italic> = 7). All experiments in (<bold>A–C</bold>) were done in the presence of hexamethonium chloride (200 µM), sulpiride (1 µM), atropine (30 nM), and CGP 55845 (200 nM) to block nAChRs, D2Rs, mAChRs, and GABA-BRs respectively.</p><p> <supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Raw values used for plots in <xref ref-type="fig" rid="fig3">Figure 3</xref> and <xref ref-type="fig" rid="fig3s1">Figure 3—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55729-fig3-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig3-v1.tif"/></fig><fig id="fig3s1" position="float" specific-use="child-fig"><label>Figure 3—figure supplement 1.</label><caption><title>GABA-A acitvation does not affect baseline dLight levels.</title><p>(<bold>A</bold>) Bath perfusion of muscimol did not significantly alter the pre-stimulation (baseline) dLight signal.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig3-figsupp1-v1.tif"/></fig></fig-group><p>Past work on parallel fibers in the cerebellum has shown that GABA produces biphasic effects on axonal excitability with low intensity GABA uncaging (<xref ref-type="bibr" rid="bib42">Khatri et al., 2019</xref>) or transient GABA-A receptor activation within a 10-20 second time window being more likely to enhance release while stronger or longer muscimol application being more likely to inhibit release (<xref ref-type="bibr" rid="bib74">Stell, 2011</xref>). To test this hypothesis on dopamine neuron axons, we activated GABA-A receptors transiently with a puffer pipette (10 µM, 1-3 s puff). Dopamine release was evoked selectively from dopaminergic fibers in dorsal striatum slices using optical activation of a channelrhodopsin variant, CoChR. Extracellular dopamine was monitored using fast-scan cyclic voltammetry. Surprisingly, we found that puff application of muscimol still resulted in inhibition of dopamine release from axons within the dorsal striatum by an average of 19.1 ± 4.2% (<xref ref-type="fig" rid="fig3">Figure 3D–F</xref>; control, <inline-formula><mml:math id="inf14"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>=94.7%; muscimol, <inline-formula><mml:math id="inf15"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>=75.7%; F(1, 6)=20.7, p=0.004; n=7 slices). Together, these results show that both transient and steady-state receptor activation of axonal GABA-A receptors results in inhibition of striatal dopamine release.</p></sec><sec id="s2-5"><title>Axonal GABA-A receptors inhibit through a combination of voltage-gated sodium channel inactivation and shunting</title><p>To better understand how axonal GABA-A receptors inhibit dopamine release, we tested the effect of GABA-A receptor activation on axonal action potential waveforms. As shown in <xref ref-type="fig" rid="fig4">Figure 4B</xref>, the most prominent effect of GABA-A receptor activation was a shortening of the action potential peak. Although the effect of GABA on spike height varied between axons, we found that the peak was shortened on average by 7.74 ± 1.83 mV (avg. peak amplitude; control, <inline-formula><mml:math id="inf16"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> = 12.5 ± 4.72 mV; GABA, <inline-formula><mml:math id="inf17"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> = 4.77 ± 5.22 mV; 2-way ANOVA Bonferroni’s post-hoc t(12)=5.75; n=7, p=0.0002). This effect was blocked completely by picrotoxin (peak reduction in picrotoxin; control peak, <inline-formula><mml:math id="inf18"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> = -1.86 ± 5.34 mV, GABA peak <inline-formula><mml:math id="inf19"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> = -3.88 ± 5.02 mV; 2-way ANOVA Bonferroni’s post-hoc t(12)=1.49; n=7, p=0.32). We took advantage of the variability between axons in their responses to GABA in order to assess the relationship between the GABA-A mediated depolarization and spike height. Plotting data from 14 axon recordings, we found that the reduction in spike height correlated linearly with the GABA-mediated depolarization with a slope of -1.50 mV/mV (95% CI: -2.05 to -0.94; R<sup>2</sup>=0.74, n=14; <xref ref-type="fig" rid="fig4">Figure 4D</xref>, fit to green symbols). Therefore, larger GABA-induced subthreshold depolarizations result in shorter axonal action potentials.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Axonal GABA-A receptors inhibit excitability through a combination of sodium channel inactivation and shunting.</title><p>(<bold>A</bold>) Schematic of the experimental setup for this figure. Whole-cell recordings were made from the main, connected, axons of dopamine neurons. (<bold>B</bold>) Example axonal recording showing the effect of a brief GABA pressure ejection. Control (gray) and GABA (green) traces magnified. <italic>B</italic>, <italic>right</italic>: Control action potential in black and GABA-affected action potential in green. (<bold>C</bold>) Similar experiment to B, except demonstrating the effect current injection on spike properties as opposed to GABA application. Purple line on AP upstroke denotes area of measurement for rate of rise, arrows denoting measurement of change in AP peak and change in membrane potential. (<bold>D</bold>) Effect of the amount of baseline depolarization on the decrease in peak AP amplitude, compared between GABA (green; n = 14) and current injection (tan; n = 15) (*p=0.047). (<bold>E</bold>) Effect of the amount of baseline depolarization on the normalized decrease in rate of AP upstroke, compared between GABA (green; n = 11) and current injection (tan; n = 10) (ns p=0.564). (<bold>F</bold>) A plot showing the relationship between decrease in rate of AP rise and decrease in AP peak, for injection of current (brown; n = 8) and a brief pressure ejection of GABA (green; n = 11). (<bold>G</bold>) Example axonal recording showing spontaneously firing action potentials before the application of TTX (<italic>top, black</italic>) and after TTX bath perfusion, just before the action potentials cease (<italic>bottom</italic>, <italic>red</italic>), <italic>inset</italic>: Example phase plots for axonal action potentials before (black) and after (red) TTX perfusion. (<bold>H</bold>) Averaged data showing the effect of TTX on action potential peak amplitude (graphs were aligned to the beginning of TTX effect, n = 5). The decrease in peak amplitude is plotted in I. (<bold>I</bold>) Data from five individual axons showing the effect of TTX wash-in on the change in rate of action potential rise, and the change in the peak of the action potential. Each dot in data from an individual action potential, normalized to just before the perfusion of TTX. In red is the average effect.</p><p> <supplementary-material id="fig4sdata1"><label>Figure 4—source data 1.</label><caption><title>Raw values used for plots in <xref ref-type="fig" rid="fig4">Figure 4</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55729-fig4-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig4-v1.tif"/></fig><p>The GABA-A mediated reduction of spike amplitude likely involves two main processes: inactivation of axonal sodium channels due to GABA-induced depolarization (<xref ref-type="bibr" rid="bib59">Rama et al., 2015</xref>) and shunting inhibition (<xref ref-type="bibr" rid="bib84">Xia et al., 2014</xref>; <xref ref-type="bibr" rid="bib17">Cattaert and El Manira, 1999</xref>). To dissect the contribution from these two processes, we compared the GABA puff experiments in <xref ref-type="fig" rid="fig4">Figure 4B</xref> to separate experiments where depolarization was evoked instead by direct current injection (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). We reasoned that the effects of current injection-evoked depolarization on spike height should be dominated by sodium channel inactivation, whereas shunting inhibition should be minimal under these conditions. Plotting the spike height against current injection-evoked depolarization in <xref ref-type="fig" rid="fig4">Figure 4D</xref> (brown symbols), we found that direct current injections were significantly less effective at reducing spike peak amplitudes as compared to GABA mediated depolarization, shown by a shallower slope of best-fit lines (<xref ref-type="fig" rid="fig4">Figure 4D</xref>; GABA-A activation: −1.50 mV/mV, 95% CI: −2.05 to −0.94; direct depolarization: −0.77 mV/mV, 95% CI: −0.96 to −0.59; F(1,25)=4.39, n = 29, p=0.047). We next analyzed the rate of the rise of the action potential (dV/dt) as it reflects the maximal spike-evoked sodium current. By contrast, we found little difference in the effect of GABA-evoked and direct current injection-evoked depolarization on the rate of rise of axonal action potentials (dV/dt). Plots in <xref ref-type="fig" rid="fig4">Figure 4E</xref> show that both manipulations slowed the rate of rise of action potentials and shared similar dependences on subthreshold depolarization (slope of linear fits; GABA-A activation: −3.78 %/mV 95% CI: −5.46 to −2.10, direct depolarization: −3.20 %/mV, 95% CI: −4.57 to −1.83; F(1,17) = 0.35, n = 21, p=0.56).</p><p>These data suggested the peak amplitude of the action potential was susceptible to both depolarizations and shunting inhibition, while the rate of rise was only affected by depolarizations. In order to combine these two effects and distinguish between shunting inhibition and depolarization-mediated inactivation of sodium channels, the change in rate of rise was graphed against the change in peak spike amplitude. From this relationship the added effect of shunting inhibition is clear in the significantly steeper relationship for GABA-A receptor activation (<xref ref-type="fig" rid="fig4">Figure 4F</xref> slope of linear fits; GABA-A activation: 0.44 mV/%, 95% CI: −0.35 to 0.52, direct depolarization: 0.18 mV/mV, 95% CI: 0.15 to 0.22; F (1,17)=39.9, n = 19, p&lt;0.0001).</p><p>To experimentally test the effect of sodium channel inhibition on axonal action potentials, TTX was bath perfused while recording axonal action potentials (<xref ref-type="fig" rid="fig4">Figure 4G</xref>). As the effect of TTX developed, the amplitude of the peak of the action potential was progressively reduced, and the rate of rise was progressively slowed (<xref ref-type="fig" rid="fig4">Figure 4G–I</xref>). We compared the relationship of the reduction in the peak and the slowing of the rate of rise across groups and found that the average of the TTX condition was similar to the direct depolarization, indicating this effect was mainly through inactivation of sodium channels. However, GABA-A receptor activation had a significantly steeper relationship, revealing the additional contribution of shunting inhibition (<xref ref-type="fig" rid="fig4">Figure 4F</xref> and <xref ref-type="fig" rid="fig4">Figure 4I</xref>).</p><p>These data show that GABA-A receptors act mechanistically through both depolarization of the axonal membrane as well as a change in the input resistance that leads to shunting inhibition. These two effects combine to slow and shorten dopaminergic action potentials.</p></sec><sec id="s2-6"><title>GABA-A receptor-mediated inhibition of axonal calcium signals increases with propagation distance</title><p>Our data show a clear inhibitory effect of axonal GABA-A conductance on dopamine release that differs from the excitatory actions of GABA-A receptors observed in most central axons. As a possible explanation for their distinctive responses, dopamine neuron axons in the dorsal striatum are distinguished by their very thin diameters and highly branched structure (<xref ref-type="bibr" rid="bib48">Matsuda et al., 2009</xref>). Under some circumstances, this feature may present a challenge for spike propagation following the GABA-A increase in shunting inhibition.</p><p>We therefore set out to determine the influence of GABA-A receptors on signals that have propagated through the extreme architecture of the dopaminergic neuron terminals. To test this, a burst of activity was evoked in axons using a bipolar electrode placed in the caudal striatum (closer to the main trunk of the axon) and axonal calcium signals were imaged distal to the site of stimulation in the rostral striatum (<inline-formula><mml:math id="inf20"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> ~ 690 ± 73.1 µm, <xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). We found that calcium signals evoked by electrical stimulation in the caudal striatum and imaged distally in the rostral striatum were significantly inhibited by GABA-A receptor activation (<xref ref-type="fig" rid="fig5">Figure 5C</xref>, muscimol <inline-formula><mml:math id="inf21"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>=36.4 ± 14.3% of baseline; Šidák’s post-hoc test t(4)=4.4; p=0.034; n=5 slices). By contrast, calcium signals evoked by local stimulation (<inline-formula><mml:math id="inf22"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula> ~ 100 ± 29.2 µm between stimulator and imaging site, <xref ref-type="fig" rid="fig5">Figure 5D–I</xref>) were not significantly affected by bath perfusion of muscimol (10 µM). This was true for axonal calcium signals evoked by local stimulation of the caudal striatum (<xref ref-type="fig" rid="fig5">Figure 5F</xref>, muscimol <inline-formula><mml:math id="inf23"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>=95.0 ± 8.4% of baseline; Šidák’s post-hoc test t(4)=0.52; p=0.95; n=5 slices) and the rostral striatum (<xref ref-type="fig" rid="fig5">Figure 5I</xref>, muscimol <inline-formula><mml:math id="inf24"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>=96.1 ± 3.2% of baseline; Šidák’s post-hoc test t(7)=1.2; p=0.61; n=8 slices). Therefore, these data show that calcium signals in dopaminergic neuron axons of the striatum are most greatly affected by GABA-A receptor activation under conditions involving action potentials that propagate long distances throughout the axonal arbor.</p><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>GABA-A receptor-mediated inhibition of axonal calcium signals increases with propagation distance.</title><p>Stimulation-evoked calcium signals in dopamine neuron axons imaged either at the site of stimulation, or distal to the site of stimulation. (<bold>A</bold>) Experimental setup diagram. (<bold>B</bold>) Stimulation-evoked GCaMP6f signals in control (<italic>black</italic>) and in response to muscimol bath application (<italic>green</italic>). (<bold>C</bold>) Time course showing a significant effect of bath applied muscimol for GCaMP6f signals imaged in the rostral striatum, stimulated caudally (~690 ± 73.1 µm between stimulation and imaging, <italic>n</italic> = 5; *p=0.034). (<bold>D</bold>) Experimental setup diagram. <bold>E</bold>) Stimulation-evoked GCaMP6f signals in control (<italic>black</italic>) and in response to muscimol bath application (<italic>green</italic>). (<bold>F</bold>) Time course showing no significant effect of bath applied muscimol for GCaMP6f signals imaged near to the site of stimulation in the caudal striatum (~100 ± 29.2 µm between stimulation and recording, <italic>n</italic> = 5, p=0.95). (<bold>G</bold>) Experimental setup diagram. <bold>H</bold>) Stimulation-evoked GCaMP6f signals in control (<italic>black</italic>) and in response to muscimol bath application (<italic>green</italic>). (<bold>I</bold>) Time course showing no significant effect of bath applied muscimol for GCaMP6f signals imaged near to the site of stimulation in the rostral striatum (&lt;100 µm between stimulation and recording, <italic>n</italic> = 8, p=0.61). In these experiments, Hexamethonium Chloride (200 µM; <xref ref-type="fig" rid="fig6">Figure 6A–F</xref>) or DhβE (1 µM; <xref ref-type="fig" rid="fig6">Figure 6G–I</xref>), sulpiride (1 µM), atropine (30 nM), and CGP 55845 (200 nM) were used to block nAChRs, D2Rs, mAChRs, and GABA-BRs respectively.</p><p> <supplementary-material id="fig5sdata1"><label>Figure 5—source data 1.</label><caption><title>Raw values used for plots in <xref ref-type="fig" rid="fig5">Figure 5</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55729-fig5-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig5-v1.tif"/></fig></sec><sec id="s2-7"><title>Benzodiazepines enhance tonic GABA activity on dopamine neuron axons</title><p>Benzodiazepines constitute a class of allosteric modulators that act on GABA-A receptors to enhance GABA-mediated currents. Much is known about the somatic mechanisms regulating the effects of benzodiazepines in dopamine neurons (<xref ref-type="bibr" rid="bib61">Reynolds et al., 2012</xref>; <xref ref-type="bibr" rid="bib78">Tan et al., 2010</xref>; <xref ref-type="bibr" rid="bib79">Tan et al., 2011</xref>); but less is known about direct axonal effects of these drugs. Studies examining the effect of benzodiazepines on dopamine release showed these effects are likely mediated through GABA-B receptors, and indirectly involved GABA-A receptors on non-dopaminergic neurons (<xref ref-type="bibr" rid="bib13">Brodnik et al., 2019</xref>). We therefore sought to determine the contribution of GABA-A receptors on dopamine neuron axons to the effects of diazepam.</p><p>We first tested the effect to inhibiting both GABA-A and GABA-B receptors in the striatum in the absence of any exogenously applied agonist. We found that co-application of GABA-A (gabazine) and GABA-B (CGP-55845) antagonists significantly enhanced dopamine release to 115% of baseline (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref>; t(9)=2.99, p=0.015, n = 10) while gabazine alone did not significantly increase dopamine release (<xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1C and D</xref>). These results are consistent with previous studies reporting a GABA tone in the striatum (<xref ref-type="bibr" rid="bib1">Ade et al., 2008</xref>; <xref ref-type="bibr" rid="bib28">Gruen et al., 1992</xref>; <xref ref-type="bibr" rid="bib45">Lopes et al., 2019</xref>).</p><p>Next, we tested the effect of the benzodiazepine diazepam on modulating axonal GABA-A receptors. To do this, we used electrical stimulation to evoke dopamine release which we imaged using dLight. Experiments were performd in a cocktail of blockers that included antagonists against dopamine D2, GABA-B, and muscarinic. We found that diazepam robustly decreased dopamine release (<xref ref-type="fig" rid="fig6">Figure 6A</xref>; diazepam: 50.7 ± 11.3% of baseline; RM 1-way ANOVA Bonferroni’s post-hoc t(4)=4.37; p=0.024, n = 5 slices). Under these conditions, a substantial amount of dopamine release is likely driven through cholinergic interneurons activation of nicotinic receptors (<xref ref-type="bibr" rid="bib15">Cachope and Cheer, 2014</xref>; <xref ref-type="bibr" rid="bib62">Rice and Cragg, 2004</xref>; <xref ref-type="bibr" rid="bib80">Threlfell et al., 2012</xref>; <xref ref-type="bibr" rid="bib89">Zhang and Sulzer, 2004</xref>). In order to isolate the diazepam effect due to direct stimulation of dopaminergic neuron axons, we imaged in a cocktail of synaptic blockers that also inhibited nicotinic receptors. In the presence of nicotinic receptors blocker, we found that diazepam application led to a weaker but still substantial inhibition of dopamine release (<xref ref-type="fig" rid="fig6">Figure 6B</xref>; diazepam: 80.6 ± 5.9% of baseline; RM 1-way ANOVA Bonferroni’s test t(5)=3.28, n = 6 slices; p=0.044). Therefore, diazepam produces a sizeable inhibition of striatal dopamine release in the presence of cholinergic interneuron-mediated transmission, but also GABA-A receptors located directly on dopamine neuron axons to inhibit dopamine release.</p><p>To understand the mechanism behind this inhibition in the dopamine neuron axons we performed direct recordings from the axon. First, we sought to investigate whether these axonal GABA-A receptors are directly modulated by diazepam. For this experiment we puffed on muscimol in a voltage-clamp recording of the main axon, and then bath perfused diazepam (10 µM). Diazepam dramatically increased the amplitude of the muscimol-evoked current (<xref ref-type="fig" rid="fig6">Figure 6C,E</xref>). We also tested the effect of diazepam on the input resistance by giving a small voltage step (<xref ref-type="fig" rid="fig6">Figure 6C</xref>). We found that, in the main axon, there was no effect of diazepam perfusion on the axonal input resistance (<xref ref-type="fig" rid="fig6">Figure 6D</xref>). This set of experiments shows that diazepam directly targets axonal GABA-A receptors on dopamine neurons, but in the medial fiber bundle GABA-A agonists must be exogenously applied to observe the effects of the drug.</p><fig-group><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Diazepam inhibits striatal dopamine release through direct effects on axonal GABA-A receptors.</title><p>(<bold>A</bold>) Example traces of imaged dopamine release from control (black) and diazepam bath perfusion (green) conditions. <italic>Right:</italic> time course showing the effect of diazepam bath perfusion on peak dopamine release (<italic>n</italic> = 5). (<bold>B</bold>) Example traces of imaged dopamine release from control (black) and diazepam bath perfusion (green) conditions with nAChRs blocked. <italic>Right:</italic> Group effect of diazepam on peak dopamine release (<italic>n</italic> = 6; *p=0.044). GABA-A Antagonists picrotoxin (100 µM) and gabazine (10 µM) were perfused at the end of each experiment. (<bold>C</bold>) Example step depolarization (<italic>left</italic>) and muscimol pressure ejection (<italic>right</italic>) recorded in the main axon in control (black) and diazepam bath application (green). Step depolarization and muscimol puff were performed within the same cell. (<bold>D</bold>) Time course showing the effect of diazepam bath application on the normalized input resistance of the main axon in the medial forebrain bundle (<italic>n</italic> = 5). (<bold>E</bold>) Time course showing the effect of diazepam bath application on the normalized muscimol-evoked peak current (<italic>n</italic> = 6). (<bold>F</bold>) Example current injections to test axonal input resistance in control (black) diazepam (green) and GABA-A antagonists picrotoxin and gabazine (red) conditions. (<bold>G</bold>) Time course of diazepam bath perfusion followed by GABA-A antagonist bath perfusion on the normalized axonal input resistance. Hexamethonium chloride (200 µM), sulpiride (1 µM), atropine (30 nM), and CGP 55845 (200 nM) were used to block nAChRs, D2Rs, mAChRs, and GABA-BRs respectively.</p><p> <supplementary-material id="fig6sdata1"><label>Figure 6—source data 1.</label><caption><title>Raw values used for plots in <xref ref-type="fig" rid="fig6">Figure 6</xref> and <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1</xref>.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-55729-fig6-data1-v1.xlsx"/></supplementary-material> </p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig6-v1.tif"/></fig><fig id="fig6s1" position="float" specific-use="child-fig"><label>Figure 6—figure supplement 1.</label><caption><title>Inhibition of GABA-A alone does not significantly enhance dopamine release.</title><p>(<bold>A</bold>) GABA-A and GABA-B antagonists significantly increased optically-evoked dopamine release measured with voltammetry. <italic>Inset:</italic> example CV plot for dopamine release. (<bold>B</bold>) <italic>Left:</italic> Example dopamine transient in control (black) and in GZ/CGP (red). <italic>Right:</italic> Plot of the average increase in peak optically-evoked dopamine release (each point is one slice; n=10, p = 0.015). (<bold>C</bold>) Bath perfusion of the GABA-A antagonist gabazine (10 µM) did not significantly alter dopamine release as measured with dLight. (<bold>D</bold>) Comparison between the average baseline dopamine release (normalized) to the average final three events in gabazine. There was no significant difference between the baseline and gabazine (<inline-formula><mml:math id="inf25"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>=126 ± 14.3% of baseline) conditions (two-tailed paired t-test, t(10)=1.8; p=0.10; n=11). Experiment was performed in the presence of CGP (200 nM), sulpiride (1 µM), atropine (30 nM), and DHβE (1 µM).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-55729-fig6-figsupp1-v1.tif"/></fig></fig-group><p>Given the effect of diazepam on dopamine release reported above, we hypothesized that diazepam might be acting in concert with the striatal GABA tone to modulate dopamine neuron axons. When we recorded from striatal dopamine neuron axons and bath perfused diazepam, we found that diazepam decreased the input resistance of the axon in the striatum by an average of 22.7 ± 6.2% (<xref ref-type="fig" rid="fig6">Figure 6F,G</xref>), without any additional application of a GABA agonist. These results indicate a tonic level of GABA-A receptor activity that is enhanced by the application of diazepam, which decreases the input resistance of dopamine neuron axons and potentiates shunting inhibition. Thus, our data provide direct evidence that diazepam targets axonal GABA-A receptors to inhibit the release of striatal dopamine.</p></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Here we examine the influence of GABA-A receptors on the excitability of dopaminergic neuron axons and the release of dopamine in the dorsal striatum. To test this, we performed whole-cell and perforated-patch recordings from the main axon located within the medial forebrain bundle as well as in the branched, signaling axon located in the striatum. Using this approach, we provide direct evidence that GABA-A receptors are present on the axons of midbrain dopaminergic neurons. We show that these receptors modulate propagation of action potentials in the axon through a combination of sodium channel inactivation and shunting inhibition. Finally, we demonstrate that diazepam (Valium), a commonly prescribed broad-spectrum benzodiazepine, enhances axonal GABA-A receptors, resulting in shunting and subsequent inhibition of dopamine release. Together, these experiments reveal the mechanisms of GABA-A receptor modulation of dopamine release and provide new insight into the role of axonal GABA-A receptors in the actions of benzodiazepines in the striatum.</p><sec id="s3-1"><title>Action potential firing in midbrain dopaminergic neuron axons</title><p>The shape of the axonal action potential and the pre-spike membrane potential are critical determinants of neurotransmitter release (<xref ref-type="bibr" rid="bib4">Augustine, 1990</xref>; <xref ref-type="bibr" rid="bib6">Awatramani et al., 2005</xref>; <xref ref-type="bibr" rid="bib24">Geiger and Jonas, 2000</xref>; <xref ref-type="bibr" rid="bib64">Rowan et al., 2016</xref>; <xref ref-type="bibr" rid="bib66">Sabatini and Regehr, 1997</xref>). Our data show that these features of axonal action potentials differ substantially from those that have been classically associated with somatic firing in dopaminergic neurons (<xref ref-type="bibr" rid="bib26">Grace and Bunney, 1983</xref>; <xref ref-type="bibr" rid="bib82">Ungless and Grace, 2012</xref>). For example, action potentials in the soma of dopamine neurons are typically broad, while we find that axonal action potentials are narrow with an average halfwidth of 0.89 ms, in agreement with studies that have reported brief presynaptic action potentials in other neuronal cell types (<xref ref-type="bibr" rid="bib2">Alle and Geiger, 2006</xref>; <xref ref-type="bibr" rid="bib24">Geiger and Jonas, 2000</xref>; <xref ref-type="bibr" rid="bib30">Hallermann et al., 2012</xref>; <xref ref-type="bibr" rid="bib43">Kole et al., 2007</xref>). We also find that action potentials are initiated from spike thresholds that are 14.3 mV more hyperpolarized than somatic spikes. Furthermore, the average non-spike voltage recorded in both the main axon and striatal axon is 6.7 mV and 8.8 mV more negative than values reported for the soma, respectively, which also fits with data from cortical layer five pyramidal neurons (<xref ref-type="bibr" rid="bib37">Hu and Bean, 2018</xref>).</p><p>The hyperpolarized axonal interspike potential has possible functional implications on the control of dopamine release. First, the hyperpolarized axonal interspike voltage would likely maximize the availability of low-threshold channels such as L- and T-type calcium channels in axons, both of which are known to couple to dopamine release in the dorsal striatum (<xref ref-type="bibr" rid="bib12">Brimblecombe et al., 2015</xref>). Second, activation of somatodendritic dopamine D2-receptors typically results in membrane hyperpolarization which then raises the question of how these receptors control axonal excitability and transmitter release. In the soma, D2-receptors have been shown to inhibit firing through activation of G-protein activated inwardly rectifying (GIRK2) potassium channels (<xref ref-type="bibr" rid="bib8">Beckstead et al., 2004</xref>) and inhibition of the sodium leak channel NALCN (<xref ref-type="bibr" rid="bib54">Philippart and Khaliq, 2018</xref>). In axons however, D2-receptors are thought to activate Kv1 channels (<xref ref-type="bibr" rid="bib47">Martel et al., 2011</xref>). The hyperpolarized membrane potential of the axon suggests that further hyperpolarization by Kv1 may be limited by the potassium reversal potential and may not be the main mechanism of dopamine inhibition. Rather, Kv1-mediated shunting and/or changes in spike shape are likely to contribute to the D2-dependent inhibition of dopamine release.</p><p>In somatic recordings of pacemaking, dopaminergic neurons exhibit a gradual depolarization of the interspike voltage thought to be critical for the generation of spontaneous activity (<xref ref-type="bibr" rid="bib39">Kang and Kitai, 1993</xref>; <xref ref-type="bibr" rid="bib41">Khaliq and Bean, 2008</xref>). By contrast, our data from distal recordings show that the slope of the interspike axonal membrane potential was shallow. The shallower interspike depolarization in the axon suggests that pacemaking in dopaminergic neurons results largely from the intrinsic excitability of the soma and dendrites. Furthermore, the hyperpolarized axonal threshold potential suggests that our recording site in the axon is distal to the site of action potential initiation, which is the axon initial segment (<xref ref-type="bibr" rid="bib33">Häusser et al., 1995</xref>; <xref ref-type="bibr" rid="bib70">Shu et al., 2007</xref>). Therefore, these observations argue against the axon as a third site of oscillation generation after the soma and dendrites (<xref ref-type="bibr" rid="bib55">Pissadaki and Bolam, 2013</xref>). It is important to note that although the mixture of conductances present in axons does not favor spontaneous activity, it is still possible that the conductances that drive somatic depolarization such as NALCN and HCN may also be present in axons. In fact, a recent study found a positive correlation between the length of the axon initial segment and the spontaneous firing rate, suggesting that the conductances present in the axon initial segment speed firing (<xref ref-type="bibr" rid="bib46">López-Jury et al., 2018</xref>; <xref ref-type="bibr" rid="bib49">Meza et al., 2018</xref>). However, a different study found that the geometry of the axon initial segment negligibly affects the firing rate (<xref ref-type="bibr" rid="bib51">Moubarak et al., 2019</xref>). In addition to the axon initial segment geometry, future work should focus on determining the axonal conductances that enable and control firing rate and spike transmission.</p></sec><sec id="s3-2"><title>Axonal GABA-A receptors on dopaminergic neuron axons are depolarizing</title><p>The published literature has shown that large differences exist in the reversal potential of axonal chloride-based conductances when comparing between neuronal cell types. For example, a careful study of the GABA reversal potential in the axon initial segment of cortical layer 2/3 pyramidal neurons demonstrated that E<sub>GABA</sub> shifts from depolarizing to hyperpolarizing with age, eventually settling at negative values near the somatic resting potential in adult mice (~ −87 mV, <xref ref-type="bibr" rid="bib63">Rinetti-Vargas et al., 2017</xref>). Similarly, hyperpolarized GABA reversal potential values were reported from proximal axons of layer five pyramidal neurons from rats (<xref ref-type="bibr" rid="bib84">Xia et al., 2014</xref>). By contrast, axonal GABA-A receptors on the mossy fiber bouton (<xref ref-type="bibr" rid="bib65">Ruiz et al., 2010</xref>), cultured Purkinje neuron terminals (<xref ref-type="bibr" rid="bib90">Zorrilla de San Martin et al., 2017</xref>) as well as axonal glycine receptors on the calyx of Held (<xref ref-type="bibr" rid="bib57">Price and Trussell, 2006</xref>) have reported axonal chloride-based conductances that are depolarizing relative to resting membrane potential.</p><p>In this study, we demonstrate that the average reversal potential of GABA-mediated currents in dopamine neuron axons, when considered relative to the average axonal interspike membrane potential of −68 mV, is also depolarized at −56 mV. Our recordings were performed in adult mice (ages 6–17 weeks, median of 15.5 weeks) suggesting that the depolarized reversal potential that we obtained represents the value in mature axons. Interestingly, the reversal potential for somatodendritic GABA currents in dopaminergic neurons is also depolarized at −63 mV due to relatively low expression of the K-Cl cotransporter KCC2 (<xref ref-type="bibr" rid="bib29">Gulácsi et al., 2003</xref>), which is similar to the average interspike membrane potential of dopamine neurons during pacemaking. Therefore, activation of somatodendritic GABA-A receptors reduces spiking primarily through shunting with relatively little change in the membrane potential.</p></sec><sec id="s3-3"><title>Mechanism of axonal GABA-A receptor mediated inhibition of striatal dopamine release</title><p>Despite the depolarized GABA reversal potential in distal axons, our findings show that activation of axonal GABA-A receptors results in inhibition of dopamine release. Although this is consistent with work from spinal cord (<xref ref-type="bibr" rid="bib18">Curtis and Lodge, 1982</xref>; <xref ref-type="bibr" rid="bib21">Eccles et al., 1961</xref>; for a review see, <xref ref-type="bibr" rid="bib81">Trigo et al., 2008</xref>), these results differ from previous studies that have found axonal GABA-A receptors enhance synaptic transmission in cerebellar parallel fibers (<xref ref-type="bibr" rid="bib20">Dellal et al., 2012</xref>; <xref ref-type="bibr" rid="bib35">Howell and Pugh, 2016</xref>; <xref ref-type="bibr" rid="bib42">Khatri et al., 2019</xref>; <xref ref-type="bibr" rid="bib58">Pugh and Jahr, 2011</xref>) hippocampal mossy fibers (<xref ref-type="bibr" rid="bib65">Ruiz et al., 2010</xref>), terminals of cerebellar Purkinje neurons (<xref ref-type="bibr" rid="bib90">Zorrilla de San Martin et al., 2017</xref>) and in layer 2/3 pyramidal neurons of the cortex (<xref ref-type="bibr" rid="bib77">Szabadics et al., 2006</xref>).</p><p>What features distinguish dopaminergic neuron axons, and contribute to the inhibitory effect of GABA-A receptors on transmitter release? The answer to this question is currently unknown. However, one possibility is that dopaminergic neurons differ dramatically from these other cell types in axonal architecture. For example, parallel fibers and mossy fibers are unbranching, or branch only infrequently. On the other hand, dopamine neuron axons are among the most branching processes in the brain, forming new bifurcations an average of 31 µm, and possessing an average total length of 467,000 µm (<xref ref-type="bibr" rid="bib48">Matsuda et al., 2009</xref>), from which we can estimate roughly 15,000 total branches per cell. Our data suggests that this unusually high frequency of branching may lead to stronger attenuation of propagating spikes. We found that activation of GABA-A receptors had only subtle effects on axonal calcium signals at proximal imaging sites while axonal calcium signals at distal imaging sites were dramatically reduced. We also provide evidence that GABA-A activation reduces the height of axonal action potentials. Perhaps the added propagation distance enhances the effects GABA-A receptors in shortening action potentials and depressing dopamine release. More generally, the density of voltage-gated sodium channels and other channels that support active propagation are challenged by axonal GABA-A receptors, which may have a stronger effect in the thin, highly branching distal axon. In some cases, therefore, the shortening of axonal action potentials may eventually lead to an increase in branch point failures. Future experiments should seek to use whole-cell axonal recordings to directly measure action potential waveforms in the striatal axon following GABA-A activation.</p><p>Past studies have proposed that presynaptic GABA-A receptors exert their effects through either shunting inhibition or sodium channel inactivation (<xref ref-type="bibr" rid="bib81">Trigo et al., 2008</xref>). Because of the lack of experimental access to the axonal compartment, however, direct tests of this hypothesis have previously been limited to large terminal structures. In the rat posterior pituitary nerve terminals, GABA was shown to produce large depolarizations that led to strong inactivation of sodium channels, while shunting was thought to play little role in inhibition of secretion from terminals (<xref ref-type="bibr" rid="bib87">Zhang and Jackson, 1993</xref>). Here, we demonstrate in the thin, unmyelinated axons of dopaminergic neurons that shunting and depolarization-mediated inactivation of sodium channels contribute nearly equally to GABA-A receptor mediated alteration of action potential shape and the subsequent inhibition of striatal dopamine release. Under conditions of tonic GABA-A receptor activation, these two inhibitory mechanisms will be especially prominent, particularly in an electrically tight compartment like the axon where tiny fluctuations of GABA-A activity can cause large changes in membrane voltage and input resistance. Furthermore, we found that these two mechanisms of inhibition differentially affect action potential waveforms. While depolarization-mediated sodium channel inactivation both reduces spike height and slows the rate of action potential rise, shunting inhibition only affects spike height.</p></sec><sec id="s3-4"><title>Effect of benzodiazepines on axons</title><p>Benzodiazepines can have rewarding effects that, in some cases, can lead to habit formation (<xref ref-type="bibr" rid="bib9">Blanco et al., 2018</xref>; <xref ref-type="bibr" rid="bib79">Tan et al., 2011</xref>). The rewarding actions of benzodiazepines are thought to involve potentiation of GABA-A receptors located on inhibitory GABAergic neuron within the VTA which then results in disinhibition of VTA dopaminergic neurons (<xref ref-type="bibr" rid="bib78">Tan et al., 2010</xref>). As is the case with other drugs of abuse that disinhibit dopamine neurons (e.g. opioids), benzodiazepines would be expected then to increase the somatic firing rate and subsequent dopamine release in the striatum. Instead, studies of awake behaving rats show that systemic diazepam administration increases the frequency of dopamine release events but decreases the amplitude of these release events (<xref ref-type="bibr" rid="bib67">Schelp et al., 2018</xref>). The apparent disparity in these results can be reconciled by our observation that axonal GABA-A receptors on dopaminergic neuron axons are enhanced by diazepam. This enhancement of GABA-A receptors leads to a decrease in dopamine release through a combination of shunting inhibition and depolarization-mediated sodium channel inactivation. Therefore, we propose that the effects of drugs that pharmacologically target GABA-A receptors such as ethanol, barbiturates, and other sedatives should be reexamined considering their potential effects on axonal GABA-A receptors.</p><p>Of note, most of these compounds that target GABA-A receptors are not direct agonists, but rather positive allosteric modulators. Diazepam, for example, has been shown to both increase single channel conductance of GABA-A receptors (<xref ref-type="bibr" rid="bib22">Eghbali et al., 1997</xref>) and increase receptor affinity for GABA (<xref ref-type="bibr" rid="bib16">Campo-Soria et al., 2006</xref>). Therefore, diazepam does not induce substantial receptor opening, but instead enhances the affinity and efficacy of orthosteric agonists, an effect that may depend on novel GABA-A receptor auxiliary subunits (<xref ref-type="bibr" rid="bib32">Han et al., 2019</xref>). Our observation that diazepam potentiates GABA-A receptors located on dopaminergic axons consequently indicates a tonic level of activation of these receptors. GABA-A receptors are well established to exhibit tonic activity, as shown by a change in holding current and a reduction in the recording RMS noise while in voltage clamp (<xref ref-type="bibr" rid="bib68">Semyanov et al., 2004</xref>). This tonic activity is also important for the mechanism of action of some drugs, such as the anticonvulsant Vigabatrin (<xref ref-type="bibr" rid="bib52">Overstreet and Westbrook, 2001</xref>), showing both physiological and pathological roles for tonic activation of GABA-A receptors in cellular physiology.</p><p>Past studies have observed tonic GABA currents on neurons in the striatum. For example, dopamine D2 receptor-expressing medium spiny neurons have been shown to exhibit GABA-A receptor-mediated tonic currents (<xref ref-type="bibr" rid="bib1">Ade et al., 2008</xref>). The tonic currents in this study were sensitive to the sodium channel blocker, tetrodotoxin, suggesting that the GABA tone originates from spontaneous synaptic release. Other work suggests that a portion of the tonic GABA in striatum is released through action potential-independent processes (<xref ref-type="bibr" rid="bib83">Wójtowicz et al., 2013</xref>). Regarding control of striatal dopamine, recent studies suggest that tonic GABA inhibits dopamine release primarily through activation of GABA-B receptors, with little to no contribution of GABA-A receptors in this process (<xref ref-type="bibr" rid="bib13">Brodnik et al., 2019</xref>; <xref ref-type="bibr" rid="bib45">Lopes et al., 2019</xref>). Our results also show that blockade of GABA-A receptors with gabazine has little effect on dopamine release under control conditions. Following application of diazepam, however, we observe a significant reduction in input resistance of dopaminergic neuron axons. Importantly, these experiments were performed in the absence of electrical or optical stimulation which argues strongly for the involvement of GABA tone in the diazepam-mediated inhibition of striatal dopamine. Together, these findings suggest that the GABA-A receptors on dopamine neuron axons are not apposed to vesicular release sites but are likely spread along the axon shaft and boutons where they are activated by extrasynaptic GABA. Therefore, modulators of GABA-A receptors such as benzodiazepines will likely function globally to influence the shape of action potentials and affect propagation by driving subthreshold depolarization and reducing axonal input resistance across the axonal arbor.</p><p>We were surprised to find that the effect of diazepam on dopamine release was strongest when cholinergic transmission was left intact. Although the precise explanation for this unknown, it is likely that the lower axonal input resistance in the presence of diazepam results in reduced integration of cholinergic input. In addition, cholinergic interneurons also have been shown to express benzodiazepine-sensitive GABA-A receptors (<xref ref-type="bibr" rid="bib86">Yan and Surmeier, 1997</xref>) and it would be interesting to determine whether these also include axonal GABA-A receptors. Lastly, cholinergic interneurons innervate multiple cell types throughout the striatum which may contribute to tonic GABA and thus may control tonic dopamine. Future studies should explore additional circuit elements that may contribute to GABAergic control of striatal dopamine release, particularly in the case of axons that participate in direct axo-axonal communication.</p><p>In sum, this report shows direct evidence for GABA-A receptors on dopamine neuron axons. These receptors act mechanistically in the axon through a combination of increased shunting inhibition and sodium channel inactivation. Functionally, this results in reduced action potential propagation through the axonal arbor and decreased dopamine release, especially distal to the site of action potential initiation. Finally, benzodiazepines act directly on axonal GABA-A receptors to enhance the effects of GABA tone in the striatum, making the axons leakier and potentially weakening subthreshold integration.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th valign="top">Reagent type <break/>(species) or resource</th><th valign="top">Designation</th><th valign="top">Source or reference</th><th valign="top">Identifiers</th><th valign="top">Additional information</th></tr></thead><tbody><tr><td valign="top">Genetic reagent (adeno-associated virus)</td><td valign="top">AAV1-hsyn-FLEX-CoChR-GFP</td><td valign="top">UNC vector core</td><td valign="top">Boyden, E.</td><td valign="top"/></tr><tr><td valign="top">Genetic reagent (adeno-associated virus)</td><td valign="top">AAV9-CAG-FLEX-TdTomato</td><td valign="top">Penn vector core</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (adeno-associated virus)</td><td valign="top">AAV9-Syn-FLEX-jGCaMP7f</td><td valign="top">Janelia</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Genetic reagent (adeno-associated virus)</td><td valign="top">AAV9-hSyn-dLight1.2</td><td valign="top">Lin Tian</td><td valign="top"/><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Streptavidin cy5 conjugate</td><td valign="top">Invitrogen</td><td valign="top">SA1011</td><td valign="top">1:1000</td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">SR95531 hydrobromide (Gabazine)</td><td valign="top">Tocris</td><td valign="top">Cat# 1262</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">SR95531 hydrobromide (Gabazine)</td><td valign="top">Hello Bio</td><td valign="top">Cat# HB0901</td><td valign="top">used only in <xref ref-type="fig" rid="fig6s1">Figure 6—figure supplement 1A and B</xref></td></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">CGP55845 hydrochloride</td><td valign="top">Tocris</td><td valign="top">Cat# 1248</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">D-AP5</td><td valign="top">Tocris</td><td valign="top">Cat# 0106</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Atropine</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# A0132</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">NBQX disodium salt</td><td valign="top">Tocris</td><td valign="top">Cat# 1044</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">(±)-Sulpiride</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# S8010</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Tetrodotoxin (TTX)</td><td valign="top">Tocris</td><td valign="top">Cat# 1078</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">λ-Aminobutyric Acid (GABA)</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# A5835</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Picrotoxin</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# P1675</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Hexamethonium Chloride</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# H2138</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Diazepam</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# D0899</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Gramicidin</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# G5002</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Muscimol</td><td valign="top">Tocris</td><td valign="top">Cat# 0289</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Gelatin from cold water fish skin</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# G7041</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">(+)-Sodium L-ascorbate</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# A4034</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Sodium Pyruvate</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# P5280</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Thiourea</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# T7875</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Triethanolamine</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# 90279</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">N,N,N’,N’-Tetrakis-(2-hydroxypropyl)ethylenediamine</td><td valign="top">TCI</td><td valign="top">Cat# T0781</td><td valign="top"/></tr><tr><td valign="top">Chemical compound, drug</td><td valign="top">Urea</td><td valign="top">MilliporeSigma</td><td valign="top">Cat# U5128</td><td valign="top"/></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">Ai95-RCL-GCaMP6f-D: Cg-Gt(ROSA)26Sor(tm95.1(CAG-GCaMP6f)Hze)/MwarJ</td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat# 028865</td><td valign="top">male and female over 6 weeks of age</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">Ai9: Gt(ROSA)26Sor(tm9(CAG-tdTomato)Hze)</td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat# 007909</td><td valign="top">male and female over 6 weeks of age</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">TH-GFP (Tg(TH-EGFP)1Gsat</td><td valign="top">NIH MMRRC</td><td valign="top"/><td valign="top">male and female over 6 weeks of age</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">C57/Bl6J Wild Type</td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat# 000664</td><td valign="top">male and female over 6 weeks of age</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">B6.SJL-Slc6a3(tm1.1(cre)Bkmn/J (DAT-IRES-cre)</td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat# 006660</td><td valign="top">male and female over 6 weeks of age</td></tr><tr><td valign="top">Strain, strain background (<italic>Mus musculus)</italic></td><td valign="top">Ai32: B6.Cg – Gt(ROSA)26Sor(tm32(CAG-COP4*H143R/EYFP)Hze)</td><td valign="top">The Jackson Laboratory</td><td valign="top">Cat#024109</td><td valign="top">male and female over 6 weeks of age</td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Igor Pro 6</td><td valign="top">Wavemetrics</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_000325">SCR_000325</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">FIJI</td><td valign="top">PMID:<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pubmed/22743772">22743772</ext-link></td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002285">SCR_002285</ext-link></td><td valign="top"><ext-link ext-link-type="uri" xlink:href="http://fiji.sc">http://fiji.sc</ext-link></td></tr><tr><td valign="top">Software, algorithm</td><td valign="top">Prism 8</td><td valign="top">GraphPad</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR_002798">SCR_002798</ext-link></td><td valign="top"/></tr><tr><td valign="top">Software, algorithm</td><td valign="top">pClamp 11</td><td valign="top">Axon Instruments</td><td valign="top">RRID:<ext-link ext-link-type="uri" xlink:href="https://scicrunch.org/resolver/SCR:011323">SCR:011323</ext-link></td><td valign="top"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>Experimental model and subject details</title><p>All animal handling and procedures were approved by the animal care and use committee (ACUC) for the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (protocol 1322). Mice of both sexes were used throughout the study. Mice that underwent viral injections were injected at postnatal day 18 or older and were used for ex vivo electrophysiology and imaging 3–12 weeks after injection. The following strains were used: DAT-Cre (SJL-Slc6a3(tm1.1(cre)Bkmn/J, The Jackson Laboratory Cat#006660); Ai95-RCL-GCaMP6f-D (Cg-Gt(ROSA)26Sor(tm95.1(CAG-GCaMP6f)Hze)/MwarJ, The Jackson Laboratory Cat#028865); Ai9 (Gt(ROSA)26Sor(tm9(CAG-tdTomato)Hze), The Jackson Laboratory Cat#007909); TH-GFP (Tg(TH-EGFP)1Gsat) NIH MMRRC; C57/Bl6J Wild Type, The Jackson Laboratory Cat#000664; Ai32 (B6.Cg – Gt(ROSA)26Sor(tm32(CAG-COP4*H143R/EYFP)Hze), The Jackson Laboratory, Cat#024109).</p></sec><sec id="s4-2"><title>Method details</title><sec id="s4-2-1"><title>Viral injections</title><p>All stereotaxic injections were conducted on a Stoelting QSI (Cat#53311). Mice were maintained under anesthesia for the duration of the injection and allowed to recover from anesthesia on a warmed pad. The AAV9-CAG-FLEX-TdTomato (Penn Vector Core), AAV-Syn-FLEX-jGCaMP7f (<xref ref-type="bibr" rid="bib19">Dana et al., 2019</xref>), and AAV9-hSyn-dLight1.2 (<xref ref-type="bibr" rid="bib53">Patriarchi et al., 2018</xref>) viruses (0.5–1 µl) were injected bilaterally into either the medial dorsal striatum (X:±1.7 Y: +0.8 Z: −3.3) or the SNc (X:±1.9 Y: −0.5 Z: −3.9) via a Hamilton syringe. At the end of the injection, the needle was raised at a rate of 0.1 to 0.2 mm per minute for 10 minutes before the needle was removed.</p></sec></sec><sec id="s4-3"><title>Slicing and electrophysiology</title><p>Brain slice experiments were performed on male and female adult mice of at least 6 weeks in age. Mice were anesthetized with isoflurane, decapitated, and brains rapidly extracted. Horizontal sections (electrophysiology, dLight, calcium imaging) or coronal sections (voltammetry) were cut at 330–400 µm thickness on a vibratome while immersed in warmed, modified, slicing ACSF containing (in mM) 198 glycerol, 2.5 KCl, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 20 HEPES, 25 NaHCO<sub>3</sub>,10 glucose, 10 MgCl<sub>2</sub>, 0.5 CaCl<sub>2</sub>, 5 Na-ascorbate, 3 Na-pyruvate, and two thiourea. Cut sections were promptly removed from the slicing chamber and incubated for 30–60 min in a heated (34°C) chamber with holding solution containing (in mM) 92 NaCl, 30 NaHCO<sub>3</sub>, 1.2 NaH<sub>2</sub>PO<sub>4</sub>, 2.5 KCl, 35 glucose, 20 HEPES, 2 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>, 5 Na-ascorbate, 3 Na-pyruvate, and 2 thiourea. Slices were then stored at room temperature and used 30 minutes to 6 hours later. Following incubation, slices were moved to a heated (33–35°C) recording chamber that was continuously perfused with recording ACSF (in mM): 125 NaCl, 25 NaHCO<sub>3</sub>, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 3.5 KCl, 10 glucose, 1 MgCl<sub>2</sub>, 2 CaCl<sub>2</sub>. Whole-cell recordings were made using borosilicate pipettes (5–10 MΩ, axon; 2–3 MΩ, soma) filled with internal solution containing (in mM) 122 KMeSO<sub>3</sub>, 9 NaCl, 1.8 MgCl<sub>2</sub>, 4 Mg-ATP, 0.3 Na-GTP, 14 phosphocreatine, 9 HEPES, 0.45 EGTA, 0.09 CaCl<sub>2</sub>, adjusted to a pH value of 7.35 with KOH. For high chloride experiments, KMeSO<sub>3</sub> was substituted with KCl.</p><p>Perforated-patch recordings were made using borosilicate pipettes (5–10 MΩ) filled with internal solution containing (in mM) 135 KCl, 10 NaCl, 2 MgCl<sub>2</sub>, 10 HEPES, 0.5 EGTA, 0.1 CaCl<sub>2</sub>, adjusted to a pH value of 7.43 with KOH, 278 mOsm. Pipette tips were back-filled first with ~1 µL of internal lacking gramicidin followed by internal containing either 4–8 (perforated-patch on the main axon) or 80–100 µg/mL (perforated-patch in the striatum) gramicidin. Patch integrity was monitored by the addition of Alexa-488 to the gramicidin-containing internal. Experiments were discarded upon visual evidence of membrane rupture (Alexa-488 entering the axon).</p><p>To enable post-hoc reconstruction, pipette solutions in some experiments included 0.1–0.3% w/v neurobiotin (Vector Labs), and 0.01 mM AlexaFluor 594 hydrazide or AlexaFluor 488 hydrazide. Current clamp recordings were manually bridge balanced. Liquid junction potential for KMeSO<sub>3</sub> based internal solutions was −8 mV and was corrected offline.</p><p>Electrical stimulation was evoked with tungsten bipolar electrodes (150 µm tip separation, MicroProbes). For experiments where the site of electrical stimulation is distal to the site of imaging or recording, electrodes were placed at the caudal end of horizontal brain slices, or at the medial end of coronal slices. Stimulations were evoked using an Isoflex (A.M.P.I.), amplitudes ranging from 0.1 to 75 V.</p><p>Pressure ejection was performed using a borosilicate micropipette pulled on a horizontal puller (pipette size ~2–4 MΩ). The pharmacological agent being tested, either GABA or muscimol, was added to a modified external solution containing (in mM): 125 NaCl, 25 NaHCO<sub>3</sub>, 1.25 NaH<sub>2</sub>PO<sub>4</sub>, 3.5 KCl, 10 HEPES, 0.01 either Alexa 488 (for experiments in DAT-Cre x Ai9 animals) or Alexa 594 (for experiments in TH-GFP animals), final osmolarity 280–290 mOsm. This puffing solution was then spin filtered, loaded into the glass pipette, and lowered to within 30–50 µm of the axon using a micro-manipulator. The puffing solution was then applied onto the axon with a short pressure ejection (80–300 ms in duration) using a PV 820 Pneumatic PicoPump (WPI).</p></sec><sec id="s4-4"><title>Fast-scan cyclic voltammetry (FSCV)</title><p>For all voltammetry experiments the method is as follows. Cylindrical carbon-fiber electrodes (CFEs) were prepared with T650 fibers (6 μm diameter,~150 μm of exposed fiber) inserted into a glass pipette and filled with KCl (3 M). Before use, the CFEs were conditioned with 8 ms long triangular voltage ramp (−0.4 to +1.2 and back to −0.4 V versus Ag/AgCl reference at 4 V/s) delivered every 15 ms. CFEs showing current above 1.8 µA or below 1.0 µA in response to the voltage ramp around 0.6 V were discarded. A triangular voltage ramp was passed through the fiber from −400 mV to 1200 mV, and returned to −400 mV. The ramp was run at a rate of 400 V/s, every 100 ms.</p><p>For voltammetry experiments performed by E.L.T., the method is as follows. Dopamine transients were evoked by a 2 ms 470 nm LED (ThorLabs) pulse every 60 seconds. Selective channel rhodopsin stimulation of dopamine neuron axons was achieved by injecting cre-dependent CoChR channel rhodopsin into the SNc of <italic>DAT-cre</italic> transgenic animals. Peak dopamine currents were calculated from voltammograms created in Igor Pro (Wavemetrics).</p><p>For voltammetry experiments performed by J.H.S., the method is as follows. Mice were anesthetized with isoflurane and sacrificed by decapitation. Brains were sliced in sagittal orientation at 240 µm thickness with a vibratome (VT-1200S Leica) in an ice-cold cutting solution containing (in mM) 225 sucrose, 13.9 NaCl, 26.2 NaHCO<sub>3</sub>, 1 NaH<sub>2</sub>PO<sub>4</sub>, 1.25 glucose, 2.5 KCl, 0.1 CaCl<sub>2</sub>, 4.9 MgCl<sub>2</sub>, and three kynurenic acid. Slices were incubated for 20 min at 33°C in artificial cerebrospinal fluid (ACSF) containing (in mM) 124 NaCl, 1 NaH<sub>2</sub>PO<sub>4</sub>, 2.5 KCl, 1.3 MgCl<sub>2</sub>, 2.5 CaCl<sub>2</sub>, 20 glucose, 26.2 NaHCO<sub>3</sub>, 0.4 ascorbic acid, and maintained at room temperature prior recordings. Slices were placed in a submerged chamber perfused at 2 ml/min with ACSF at 32°C using an in-line heater (Harvard Apparatus).</p><p>DA transients were evoked by brief light pulse (0.6–0.8 ms) through an optical fiber (200 µm/0.22 NA) connected to a 470 nm LED (2 mW; ThorLabs) delivered every 2 min. Data were collected with a modified electrochemical headstage (CB-7B/EC retrofit with 5 MΩ resistor) using a Multiclamp 700B amplifier (Molecular Devices) after being low-pass filtered at 10 kHz and digitized at 100 kHz using custom-written software in Igor Pro named VIGOR (<xref ref-type="bibr" rid="bib11">Bock and Shin, 2018</xref>; <xref ref-type="bibr" rid="bib10">Bock, 2018</xref>) running mafPC software (<xref ref-type="bibr" rid="bib85">Xu-Friedman, 2019</xref>). Decay time constants were obtained with a single exponential fit of the derivative of the falling phase of DA transient curve.</p></sec><sec id="s4-5"><title>Fluorescent imaging</title><p>Calcium was measured in dopamine neuron axons of the medial dorsal striatum using the GCaMP6f mouse bred with the DAT-Cre mouse, or with viral injection of CRE-dependent jGCaMP7f into the SNc of DAT-cre mice. These data were combined in the results. All calcium imaging experiments were performed in the presence of atropine (30 nM), sulpiride (1 µM), hexamethonium chloride (200 µM), and CGP55845 (200 nM). A white light LED (Thorlabs; SOLIS-3C) was used in combination with a GFP filter set. A photodiode (New Focus) was mounted on the top port of the Olympus BX-51WI microscope.</p></sec><sec id="s4-6"><title>Immunohistochemistry, clearing, confocal imaging, and neural reconstructions</title><p>After electrophysiology or imaging, slices were fixed overnight in 4% paraformaldehyde (PFA) diluted in phosphate buffer (PB, 0.1M, pH 7.6). Slices were subsequently stored in PB until immunostaining and cleared using a modified CUBIC protocol, chosen because it does not quench endogenous fluorescence (<xref ref-type="bibr" rid="bib76">Susaki et al., 2015</xref>). For the immunostaining/CUBIC clearing, all steps were performed at room temperature on a shaker plate. Slices were placed in CUBIC reagent 1 for 1–2 days, washed in PB 3 × 1 hour each, placed in blocking solution (0.5% fish gelatin (MilliporeSigma) in PB) for 3 hours. Slices were directly placed in streptavidin-Cy5 conjugate at a concentration of 1:1000 in PB for 2–3 days. Slices were washed 3 times for 2 hr each and were then placed in CUBIC reagent two overnight. Slices were mounted on slides in reagent two in frame-seal incubation chambers (Bio-Rad SLF0601) and coverslipped (#2 glass). Slices were imaged through 20×, 0.8 nA and 5×, 0.3 nA objectives on an LSM 800 confocal microscope (Zeiss), and taken as tiled z-stacks using Zen Blue software in the NINDS light imaging facility.</p><p>Main axons were reconstructed and measured using Simple Neurite Tracer in FIJI (<xref ref-type="bibr" rid="bib44">Longair et al., 2011</xref>). Of axons with a positively identified soma, the majority were found in the substantia nigra <italic>pars compacta</italic>, with some found in the ventral tegmental area. Striatal axons were reconstructed using Neurolucida (MBF bioscience).</p></sec><sec id="s4-7"><title>Drugs</title><p>All salts and all drugs not otherwise stated were from MilliporeSigma. Fluo5F and Alexa594 (Life Technologies), gabazine, d-AP5, hexamethonium chloride, oxotremorine M, GABA, and muscimol, were dissolved in deionized water. Sulpiride, quinpirole, picrotoxin, CGP55845 (Tocris), NBQX, and diazepam were dissolved in DMSO. Atropine was dissolved in DMSO and then diluted 1:10 in deionized water.</p></sec><sec id="s4-8"><title>Quantification and statistical analysis</title><p>Analysis was conducted in Igor Pro and Prism 8 (GraphPad). Data in text are reported as mean (<inline-formula><mml:math id="inf26"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>-</mml:mo></mml:mover></mml:math></inline-formula>) ± SEM for parametric or median (<inline-formula><mml:math id="inf27"><mml:mover accent="true"><mml:mrow><mml:mi>x</mml:mi></mml:mrow><mml:mo>~</mml:mo></mml:mover></mml:math></inline-formula>) for non-parametric data. Error bars on graphs are indicated as ± SEM. Box plots show medians, 25 and 75% (boxes) percentiles, and 10 and 90% (whiskers) percentiles. For parametric data, t-tests were used for two-group comparison, and ANOVA tests were used for more than two group comparisons, followed by a Bonferonni or Šidák post-hoc test for analysis of multiple comparisons. For non-parametric data sets, Mann-Whitney U tests were used to compare two groups while the Kruskal-Wallis test was used to compare more than two groups. For linear regression analysis, the Straight Line analysis function was used in Prism, and an extra sum-of-squares F test was performed to determine significant differences in slope between data sets on the same plot, and to determine whether a line or exponential decay model fits the data better. For exponential fits, the One Phase Decay analysis function in Prism was used to fit a standard curve.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>We would like to thank Dr. Veronica Alvarez (NIAAA) for input on experiments and sharing lab equipment for voltammetry experiments, and to Dr. Carolyn Smith and the NINDS Light Imaging Facility for the training and equipment to take confocal images of cleared tissue. Finally, we would like to acknowledge the Khaliq lab for their input on experiments, data presentation and the text. Funding for this research was provided by an NINDS intramural research program grant NS003134 to ZMK and a Center for Compulsive Behaviors fellowship, Intramural Research Program, NIH, awarded to PFK.</p></ack><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Resources, Data curation, Software, Formal analysis, Validation, Investigation, Visualization, Methodology, Writing - original draft, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Formal analysis, Investigation, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Resources, Methodology</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Animal experimentation: All animal handling and were approved by the animal care and use committee (ACUC) for the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health under Animal Study Proposal (ASP) #1322. All surgery was performed under isoflurane anesthesia, followed by close monitoring and treatment. Every effort was made to minimize suffering.</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="pdf" mimetype="application" xlink:href="elife-55729-transrepform-v1.pdf"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>Data files containing data shown in Figures 1-6 have been provided.</p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ade</surname> <given-names>KK</given-names></name><name><surname>Janssen</surname> <given-names>MJ</given-names></name><name><surname>Ortinski</surname> <given-names>PI</given-names></name><name><surname>Vicini</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Differential tonic GABA conductances in striatal medium spiny neurons</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>1185</fpage><lpage>1197</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3908-07.2008</pub-id><pub-id pub-id-type="pmid">18234896</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alle</surname> <given-names>H</given-names></name><name><surname>Geiger</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Combined analog and action potential coding in hippocampal mossy fibers</article-title><source>Science</source><volume>311</volume><fpage>1290</fpage><lpage>1293</lpage><pub-id pub-id-type="doi">10.1126/science.1119055</pub-id><pub-id pub-id-type="pmid">16513983</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aransay</surname> <given-names>A</given-names></name><name><surname>Rodríguez-López</surname> <given-names>C</given-names></name><name><surname>García-Amado</surname> <given-names>M</given-names></name><name><surname>Clascá</surname> <given-names>F</given-names></name><name><surname>Prensa</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Long-range projection neurons of the mouse ventral tegmental area: a single-cell axon tracing analysis</article-title><source>Frontiers in Neuroanatomy</source><volume>9</volume><elocation-id>59</elocation-id><pub-id pub-id-type="doi">10.3389/fnana.2015.00059</pub-id><pub-id pub-id-type="pmid">26042000</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Augustine</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>Regulation of transmitter release at the squid giant synapse by presynaptic delayed rectifier potassium current</article-title><source>The Journal of Physiology</source><volume>431</volume><fpage>343</fpage><lpage>364</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1990.sp018333</pub-id><pub-id pub-id-type="pmid">1983120</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Avshalumov</surname> <given-names>MV</given-names></name><name><surname>Chen</surname> <given-names>BT</given-names></name><name><surname>Marshall</surname> <given-names>SP</given-names></name><name><surname>Peña</surname> <given-names>DM</given-names></name><name><surname>Rice</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Glutamate-dependent inhibition of dopamine release in striatum is mediated by a new diffusible messenger, H2O2</article-title><source>The Journal of Neuroscience</source><volume>23</volume><fpage>2744</fpage><lpage>2750</lpage><pub-id pub-id-type="pmid">12684460</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awatramani</surname> <given-names>GB</given-names></name><name><surname>Price</surname> <given-names>GD</given-names></name><name><surname>Trussell</surname> <given-names>LO</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Modulation of transmitter release by presynaptic resting potential and background calcium levels</article-title><source>Neuron</source><volume>48</volume><fpage>109</fpage><lpage>121</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2005.08.038</pub-id><pub-id pub-id-type="pmid">16202712</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachhuber</surname> <given-names>MA</given-names></name><name><surname>Hennessy</surname> <given-names>S</given-names></name><name><surname>Cunningham</surname> <given-names>CO</given-names></name><name><surname>Starrels</surname> <given-names>JL</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Increasing benzodiazepine prescriptions and overdose mortality in the united states, 1996-2013</article-title><source>American Journal of Public Health</source><volume>106</volume><fpage>686</fpage><lpage>688</lpage><pub-id pub-id-type="doi">10.2105/AJPH.2016.303061</pub-id><pub-id pub-id-type="pmid">26890165</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beckstead</surname> <given-names>MJ</given-names></name><name><surname>Grandy</surname> <given-names>DK</given-names></name><name><surname>Wickman</surname> <given-names>K</given-names></name><name><surname>Williams</surname> <given-names>JT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons</article-title><source>Neuron</source><volume>42</volume><fpage>939</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2004.05.019</pub-id><pub-id pub-id-type="pmid">15207238</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname> <given-names>C</given-names></name><name><surname>Han</surname> <given-names>B</given-names></name><name><surname>Jones</surname> <given-names>CM</given-names></name><name><surname>Johnson</surname> <given-names>K</given-names></name><name><surname>Compton</surname> <given-names>WM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Prevalence and correlates of benzodiazepine use, misuse, and use disorders among adults in the united states</article-title><source>The Journal of Clinical Psychiatry</source><volume>79</volume><elocation-id>18m12174</elocation-id><pub-id pub-id-type="doi">10.4088/JCP.18m12174</pub-id><pub-id pub-id-type="pmid">30403446</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bock</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2018">2018</year><source>Bitbucket</source><version designator="f0945c8">f0945c8</version><ext-link ext-link-type="uri" xlink:href="http://bitbucket.org/r-bock/common-igor-functions/">http://bitbucket.org/r-bock/common-igor-functions/</ext-link></element-citation></ref><ref id="bib11"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Bock</surname> <given-names>R</given-names></name><name><surname>Shin</surname> <given-names>JH</given-names></name></person-group><year iso-8601-date="2018">2018</year><source>Bitbucket</source><version designator="d8dfdd4">d8dfdd4</version><ext-link ext-link-type="uri" xlink:href="http://bitbucket.org/r-bock/vigor">http://bitbucket.org/r-bock/vigor</ext-link></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brimblecombe</surname> <given-names>KR</given-names></name><name><surname>Gracie</surname> <given-names>CJ</given-names></name><name><surname>Platt</surname> <given-names>NJ</given-names></name><name><surname>Cragg</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains</article-title><source>The Journal of Physiology</source><volume>593</volume><fpage>929</fpage><lpage>946</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.2014.285890</pub-id><pub-id pub-id-type="pmid">25533038</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brodnik</surname> <given-names>ZD</given-names></name><name><surname>Batra</surname> <given-names>A</given-names></name><name><surname>Oleson</surname> <given-names>EB</given-names></name><name><surname>España</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Local GAB<sub>AA</sub> Receptor-Mediated Suppression of Dopamine Release within the Nucleus Accumbens</article-title><source>ACS Chemical Neuroscience</source><volume>10</volume><fpage>1978</fpage><lpage>1985</lpage><pub-id pub-id-type="doi">10.1021/acschemneuro.8b00268</pub-id><pub-id pub-id-type="pmid">30253088</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cachope</surname> <given-names>R</given-names></name><name><surname>Mateo</surname> <given-names>Y</given-names></name><name><surname>Mathur</surname> <given-names>BN</given-names></name><name><surname>Irving</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>HL</given-names></name><name><surname>Morales</surname> <given-names>M</given-names></name><name><surname>Lovinger</surname> <given-names>DM</given-names></name><name><surname>Cheer</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: setting the tone for reward processing</article-title><source>Cell Reports</source><volume>2</volume><fpage>33</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2012.05.011</pub-id><pub-id pub-id-type="pmid">22840394</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cachope</surname> <given-names>R</given-names></name><name><surname>Cheer</surname> <given-names>JF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Local control of striatal dopamine release</article-title><source>Frontiers in Behavioral Neuroscience</source><volume>8</volume><elocation-id>188</elocation-id><pub-id pub-id-type="doi">10.3389/fnbeh.2014.00188</pub-id><pub-id pub-id-type="pmid">24904339</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campo-Soria</surname> <given-names>C</given-names></name><name><surname>Chang</surname> <given-names>Y</given-names></name><name><surname>Weiss</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Mechanism of action of benzodiazepines on GABAA receptors</article-title><source>British Journal of Pharmacology</source><volume>148</volume><fpage>984</fpage><lpage>990</lpage><pub-id pub-id-type="doi">10.1038/sj.bjp.0706796</pub-id><pub-id pub-id-type="pmid">16783415</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cattaert</surname> <given-names>D</given-names></name><name><surname>El Manira</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>Shunting versus inactivation: analysis of presynaptic inhibitory mechanisms in primary afferents of the crayfish</article-title><source>The Journal of Neuroscience</source><volume>19</volume><fpage>6079</fpage><lpage>6089</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-14-06079.1999</pub-id><pub-id pub-id-type="pmid">10407044</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curtis</surname> <given-names>DR</given-names></name><name><surname>Lodge</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>The depolarization of feline ventral horn group Ia spinal afferent terminations by GABA</article-title><source>Experimental Brain Research</source><volume>46</volume><fpage>215</fpage><lpage>233</lpage><pub-id pub-id-type="doi">10.1007/BF00237180</pub-id><pub-id pub-id-type="pmid">6124445</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dana</surname> <given-names>H</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Mohar</surname> <given-names>B</given-names></name><name><surname>Hulse</surname> <given-names>BK</given-names></name><name><surname>Kerlin</surname> <given-names>AM</given-names></name><name><surname>Hasseman</surname> <given-names>JP</given-names></name><name><surname>Tsegaye</surname> <given-names>G</given-names></name><name><surname>Tsang</surname> <given-names>A</given-names></name><name><surname>Wong</surname> <given-names>A</given-names></name><name><surname>Patel</surname> <given-names>R</given-names></name><name><surname>Macklin</surname> <given-names>JJ</given-names></name><name><surname>Chen</surname> <given-names>Y</given-names></name><name><surname>Konnerth</surname> <given-names>A</given-names></name><name><surname>Jayaraman</surname> <given-names>V</given-names></name><name><surname>Looger</surname> <given-names>LL</given-names></name><name><surname>Schreiter</surname> <given-names>ER</given-names></name><name><surname>Svoboda</surname> <given-names>K</given-names></name><name><surname>Kim</surname> <given-names>DS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High-performance calcium sensors for imaging activity in neuronal populations and microcompartments</article-title><source>Nature Methods</source><volume>16</volume><fpage>649</fpage><lpage>657</lpage><pub-id pub-id-type="doi">10.1038/s41592-019-0435-6</pub-id><pub-id pub-id-type="pmid">31209382</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dellal</surname> <given-names>SS</given-names></name><name><surname>Luo</surname> <given-names>R</given-names></name><name><surname>Otis</surname> <given-names>TS</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>GABAA receptors increase excitability and conduction velocity of cerebellar parallel fiber axons</article-title><source>Journal of Neurophysiology</source><volume>107</volume><fpage>2958</fpage><lpage>3028</lpage><pub-id pub-id-type="doi">10.1152/jn.01028.2011</pub-id><pub-id pub-id-type="pmid">22378171</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eccles</surname> <given-names>JC</given-names></name><name><surname>Eccles</surname> <given-names>RM</given-names></name><name><surname>Magni</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1961">1961</year><article-title>Central inhibitory action attributable to presynaptic depolarization produced by muscle afferent volleys</article-title><source>The Journal of Physiology</source><volume>159</volume><fpage>147</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1113/jphysiol.1961.sp006798</pub-id><pub-id pub-id-type="pmid">13889050</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eghbali</surname> <given-names>M</given-names></name><name><surname>Curmi</surname> <given-names>JP</given-names></name><name><surname>Birnir</surname> <given-names>B</given-names></name><name><surname>Gage</surname> <given-names>PW</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Hippocampal GABA(A) channel conductance increased by diazepam</article-title><source>Nature</source><volume>388</volume><fpage>71</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1038/40404</pub-id><pub-id pub-id-type="pmid">9214504</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ford</surname> <given-names>CP</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The role of D2-autoreceptors in regulating dopamine neuron activity and transmission</article-title><source>Neuroscience</source><volume>282</volume><fpage>13</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2014.01.025</pub-id><pub-id pub-id-type="pmid">24463000</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geiger</surname> <given-names>JR</given-names></name><name><surname>Jonas</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Dynamic control of presynaptic ca(2+) inflow by fast-inactivating K(+) channels in hippocampal mossy fiber boutons</article-title><source>Neuron</source><volume>28</volume><fpage>927</fpage><lpage>939</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)00164-1</pub-id><pub-id pub-id-type="pmid">11163277</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giorguieff</surname> <given-names>MF</given-names></name><name><surname>Kemel</surname> <given-names>ML</given-names></name><name><surname>Glowinski</surname> <given-names>J</given-names></name><name><surname>Besson</surname> <given-names>MJ</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>Stimulation of dopamine release by GABA in rat striatal slices</article-title><source>Brain Research</source><volume>139</volume><fpage>115</fpage><lpage>130</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(78)90064-1</pub-id><pub-id pub-id-type="pmid">620345</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname> <given-names>AA</given-names></name><name><surname>Bunney</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="1983">1983</year><article-title>Intracellular and extracellular electrophysiology of nigral dopaminergic neurons--1. identification and characterization</article-title><source>Neuroscience</source><volume>10</volume><fpage>301</fpage><lpage>315</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(83)90135-5</pub-id><pub-id pub-id-type="pmid">6633863</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grace</surname> <given-names>AA</given-names></name><name><surname>Bunney</surname> <given-names>BS</given-names></name></person-group><year iso-8601-date="1984">1984</year><article-title>The control of firing pattern in nigral dopamine neurons: single spike firing</article-title><source>The Journal of Neuroscience</source><volume>4</volume><fpage>2866</fpage><lpage>2876</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.04-11-02866.1984</pub-id><pub-id pub-id-type="pmid">6150070</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gruen</surname> <given-names>RJ</given-names></name><name><surname>Friedhoff</surname> <given-names>AJ</given-names></name><name><surname>Coale</surname> <given-names>A</given-names></name><name><surname>Moghaddam</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1992">1992</year><article-title>Tonic inhibition of striatal dopamine transmission: effects of benzodiazepine and GABAA receptor antagonists on extracellular dopamine levels</article-title><source>Brain Research</source><volume>599</volume><fpage>51</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(92)90851-Y</pub-id><pub-id pub-id-type="pmid">1337302</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gulácsi</surname> <given-names>A</given-names></name><name><surname>Lee</surname> <given-names>CR</given-names></name><name><surname>Sík</surname> <given-names>A</given-names></name><name><surname>Viitanen</surname> <given-names>T</given-names></name><name><surname>Kaila</surname> <given-names>K</given-names></name><name><surname>Tepper</surname> <given-names>JM</given-names></name><name><surname>Freund</surname> <given-names>TF</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Cell type-specific differences in chloride-regulatory mechanisms and GABA(A) receptor-mediated inhibition in rat substantia nigra</article-title><source>The Journal of Neuroscience</source><volume>23</volume><fpage>8237</fpage><lpage>8246</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-23-08237.2003</pub-id><pub-id pub-id-type="pmid">12967985</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hallermann</surname> <given-names>S</given-names></name><name><surname>de Kock</surname> <given-names>CP</given-names></name><name><surname>Stuart</surname> <given-names>GJ</given-names></name><name><surname>Kole</surname> <given-names>MH</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>State and location dependence of action potential metabolic cost in cortical pyramidal neurons</article-title><source>Nature Neuroscience</source><volume>15</volume><fpage>1007</fpage><lpage>1014</lpage><pub-id pub-id-type="doi">10.1038/nn.3132</pub-id><pub-id pub-id-type="pmid">22660478</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamid</surname> <given-names>AA</given-names></name><name><surname>Pettibone</surname> <given-names>JR</given-names></name><name><surname>Mabrouk</surname> <given-names>OS</given-names></name><name><surname>Hetrick</surname> <given-names>VL</given-names></name><name><surname>Schmidt</surname> <given-names>R</given-names></name><name><surname>Vander Weele</surname> <given-names>CM</given-names></name><name><surname>Kennedy</surname> <given-names>RT</given-names></name><name><surname>Aragona</surname> <given-names>BJ</given-names></name><name><surname>Berke</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mesolimbic dopamine signals the value of work</article-title><source>Nature Neuroscience</source><volume>19</volume><fpage>117</fpage><lpage>126</lpage><pub-id pub-id-type="doi">10.1038/nn.4173</pub-id><pub-id pub-id-type="pmid">26595651</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname> <given-names>W</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Pelkey</surname> <given-names>KA</given-names></name><name><surname>Pandey</surname> <given-names>S</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name><name><surname>Wang</surname> <given-names>YX</given-names></name><name><surname>Wu</surname> <given-names>K</given-names></name><name><surname>Ge</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Castellano</surname> <given-names>D</given-names></name><name><surname>Liu</surname> <given-names>C</given-names></name><name><surname>Wu</surname> <given-names>LG</given-names></name><name><surname>Petralia</surname> <given-names>RS</given-names></name><name><surname>Lynch</surname> <given-names>JW</given-names></name><name><surname>McBain</surname> <given-names>CJ</given-names></name><name><surname>Lu</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Shisa7 is a GAB<sub>AA</sub> receptor auxiliary subunit controlling benzodiazepine actions</article-title><source>Science</source><volume>366</volume><fpage>246</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1126/science.aax5719</pub-id><pub-id pub-id-type="pmid">31601770</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Häusser</surname> <given-names>M</given-names></name><name><surname>Stuart</surname> <given-names>G</given-names></name><name><surname>Racca</surname> <given-names>C</given-names></name><name><surname>Sakmann</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Axonal initiation and active dendritic propagation of action potentials in substantia nigra neurons</article-title><source>Neuron</source><volume>15</volume><fpage>637</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/0896-6273(95)90152-3</pub-id><pub-id pub-id-type="pmid">7546743</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heikkinen</surname> <given-names>AE</given-names></name><name><surname>Möykkynen</surname> <given-names>TP</given-names></name><name><surname>Korpi</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Long-lasting modulation of glutamatergic transmission in VTA dopamine neurons after a single dose of benzodiazepine agonists</article-title><source>Neuropsychopharmacology</source><volume>34</volume><fpage>290</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1038/npp.2008.89</pub-id><pub-id pub-id-type="pmid">18563060</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname> <given-names>RD</given-names></name><name><surname>Pugh</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Biphasic modulation of parallel fibre synaptic transmission by co-activation of presynaptic GABAA and GABAB receptors in mice</article-title><source>The Journal of Physiology</source><volume>594</volume><fpage>3651</fpage><lpage>3717</lpage><pub-id pub-id-type="doi">10.1113/JP272124</pub-id><pub-id pub-id-type="pmid">27061582</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Tian</surname> <given-names>C</given-names></name><name><surname>Li</surname> <given-names>T</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Hou</surname> <given-names>H</given-names></name><name><surname>Shu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Distinct contributions of na(v)1.6 and na(v)1.2 in action potential initiation and backpropagation</article-title><source>Nature Neuroscience</source><volume>12</volume><fpage>996</fpage><lpage>1002</lpage><pub-id pub-id-type="doi">10.1038/nn.2359</pub-id><pub-id pub-id-type="pmid">19633666</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Bean</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Differential control of axonal and somatic resting potential by Voltage-Dependent conductances in cortical layer 5 pyramidal neurons</article-title><source>Neuron</source><volume>99</volume><elocation-id>1355</elocation-id><pub-id pub-id-type="doi">10.1016/j.neuron.2018.08.042</pub-id><pub-id pub-id-type="pmid">30236286</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname> <given-names>W</given-names></name><name><surname>Shu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Axonal bleb recording</article-title><source>Neuroscience Bulletin</source><volume>28</volume><fpage>342</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1007/s12264-012-1247-1</pub-id><pub-id pub-id-type="pmid">22833034</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname> <given-names>Y</given-names></name><name><surname>Kitai</surname> <given-names>ST</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>A whole cell patch-clamp study on the pacemaker potential in dopaminergic neurons of rat substantia nigra Compacta</article-title><source>Neuroscience Research</source><volume>18</volume><fpage>209</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1016/0168-0102(93)90056-V</pub-id><pub-id pub-id-type="pmid">8127469</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kauer</surname> <given-names>JA</given-names></name><name><surname>Malenka</surname> <given-names>RC</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Synaptic plasticity and addiction</article-title><source>Nature Reviews Neuroscience</source><volume>8</volume><fpage>844</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1038/nrn2234</pub-id><pub-id pub-id-type="pmid">17948030</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaliq</surname> <given-names>ZM</given-names></name><name><surname>Bean</surname> <given-names>BP</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Dynamic, nonlinear feedback regulation of slow pacemaking by A-type potassium current in ventral tegmental area neurons</article-title><source>Journal of Neuroscience</source><volume>28</volume><fpage>10905</fpage><lpage>10917</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2237-08.2008</pub-id><pub-id pub-id-type="pmid">18945898</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khatri</surname> <given-names>SN</given-names></name><name><surname>Wu</surname> <given-names>WC</given-names></name><name><surname>Yang</surname> <given-names>Y</given-names></name><name><surname>Pugh</surname> <given-names>JR</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Direction of action of presynaptic GAB<sub>AA</sub> receptors is highly dependent on the level of receptor activation</article-title><source>Journal of Neurophysiology</source><volume>121</volume><fpage>1896</fpage><lpage>1905</lpage><pub-id pub-id-type="doi">10.1152/jn.00779.2018</pub-id><pub-id pub-id-type="pmid">30892973</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kole</surname> <given-names>MH</given-names></name><name><surname>Letzkus</surname> <given-names>JJ</given-names></name><name><surname>Stuart</surname> <given-names>GJ</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Axon initial segment Kv1 channels control axonal action potential waveform and synaptic efficacy</article-title><source>Neuron</source><volume>55</volume><fpage>633</fpage><lpage>647</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2007.07.031</pub-id><pub-id pub-id-type="pmid">17698015</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longair</surname> <given-names>MH</given-names></name><name><surname>Baker</surname> <given-names>DA</given-names></name><name><surname>Armstrong</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Simple neurite tracer: open source software for reconstruction, visualization and analysis of neuronal processes</article-title><source>Bioinformatics</source><volume>27</volume><fpage>2453</fpage><lpage>2454</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btr390</pub-id><pub-id pub-id-type="pmid">21727141</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopes</surname> <given-names>EF</given-names></name><name><surname>Roberts</surname> <given-names>BM</given-names></name><name><surname>Siddorn</surname> <given-names>RE</given-names></name><name><surname>Clements</surname> <given-names>MA</given-names></name><name><surname>Cragg</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inhibition of nigrostriatal dopamine release by striatal GABAA and GABAB Receptors</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>1058</fpage><lpage>1065</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2028-18.2018</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>López-Jury</surname> <given-names>L</given-names></name><name><surname>Meza</surname> <given-names>RC</given-names></name><name><surname>Brown</surname> <given-names>MTC</given-names></name><name><surname>Henny</surname> <given-names>P</given-names></name><name><surname>Canavier</surname> <given-names>CC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Morphological and biophysical determinants of the intracellular and extracellular waveforms in nigral dopaminergic neurons: a computational study</article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>8295</fpage><lpage>8310</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.0651-18.2018</pub-id><pub-id pub-id-type="pmid">30104340</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martel</surname> <given-names>P</given-names></name><name><surname>Leo</surname> <given-names>D</given-names></name><name><surname>Fulton</surname> <given-names>S</given-names></name><name><surname>Bérard</surname> <given-names>M</given-names></name><name><surname>Trudeau</surname> <given-names>LE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Role of Kv1 potassium channels in regulating dopamine release and presynaptic D2 receptor function</article-title><source>PLOS ONE</source><volume>6</volume><elocation-id>e20402</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0020402</pub-id><pub-id pub-id-type="pmid">21647367</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuda</surname> <given-names>W</given-names></name><name><surname>Furuta</surname> <given-names>T</given-names></name><name><surname>Nakamura</surname> <given-names>KC</given-names></name><name><surname>Hioki</surname> <given-names>H</given-names></name><name><surname>Fujiyama</surname> <given-names>F</given-names></name><name><surname>Arai</surname> <given-names>R</given-names></name><name><surname>Kaneko</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum</article-title><source>Journal of Neuroscience</source><volume>29</volume><fpage>444</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4029-08.2009</pub-id><pub-id pub-id-type="pmid">19144844</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meza</surname> <given-names>RC</given-names></name><name><surname>López-Jury</surname> <given-names>L</given-names></name><name><surname>Canavier</surname> <given-names>CC</given-names></name><name><surname>Henny</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Role of the axon initial segment in the control of spontaneous frequency of nigral dopaminergic neurons <italic>In Vivo</italic></article-title><source>The Journal of Neuroscience</source><volume>38</volume><fpage>733</fpage><lpage>744</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1432-17.2017</pub-id><pub-id pub-id-type="pmid">29217687</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mohebi</surname> <given-names>A</given-names></name><name><surname>Pettibone</surname> <given-names>JR</given-names></name><name><surname>Hamid</surname> <given-names>AA</given-names></name><name><surname>Wong</surname> <given-names>JT</given-names></name><name><surname>Vinson</surname> <given-names>LT</given-names></name><name><surname>Patriarchi</surname> <given-names>T</given-names></name><name><surname>Tian</surname> <given-names>L</given-names></name><name><surname>Kennedy</surname> <given-names>RT</given-names></name><name><surname>Berke</surname> <given-names>JD</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Dissociable dopamine dynamics for learning and motivation</article-title><source>Nature</source><volume>570</volume><fpage>65</fpage><lpage>70</lpage><pub-id pub-id-type="doi">10.1038/s41586-019-1235-y</pub-id><pub-id pub-id-type="pmid">31118513</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moubarak</surname> <given-names>E</given-names></name><name><surname>Engel</surname> <given-names>D</given-names></name><name><surname>Dufour</surname> <given-names>MA</given-names></name><name><surname>Tapia</surname> <given-names>M</given-names></name><name><surname>Tell</surname> <given-names>F</given-names></name><name><surname>Goaillard</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Robustness to axon initial segment variation is explained by somatodendritic excitability in rat substantia nigra dopaminergic neurons</article-title><source>The Journal of Neuroscience</source><volume>39</volume><fpage>5044</fpage><lpage>5063</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2781-18.2019</pub-id><pub-id pub-id-type="pmid">31028116</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Overstreet</surname> <given-names>LS</given-names></name><name><surname>Westbrook</surname> <given-names>GL</given-names></name></person-group><year iso-8601-date="2001">2001</year><article-title>Paradoxical reduction of synaptic inhibition by vigabatrin</article-title><source>Journal of Neurophysiology</source><volume>86</volume><fpage>596</fpage><lpage>603</lpage><pub-id pub-id-type="doi">10.1152/jn.2001.86.2.596</pub-id><pub-id pub-id-type="pmid">11495935</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patriarchi</surname> <given-names>T</given-names></name><name><surname>Cho</surname> <given-names>JR</given-names></name><name><surname>Merten</surname> <given-names>K</given-names></name><name><surname>Howe</surname> <given-names>MW</given-names></name><name><surname>Marley</surname> <given-names>A</given-names></name><name><surname>Xiong</surname> <given-names>WH</given-names></name><name><surname>Folk</surname> <given-names>RW</given-names></name><name><surname>Broussard</surname> <given-names>GJ</given-names></name><name><surname>Liang</surname> <given-names>R</given-names></name><name><surname>Jang</surname> <given-names>MJ</given-names></name><name><surname>Zhong</surname> <given-names>H</given-names></name><name><surname>Dombeck</surname> <given-names>D</given-names></name><name><surname>von Zastrow</surname> <given-names>M</given-names></name><name><surname>Nimmerjahn</surname> <given-names>A</given-names></name><name><surname>Gradinaru</surname> <given-names>V</given-names></name><name><surname>Williams</surname> <given-names>JT</given-names></name><name><surname>Tian</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Ultrafast neuronal imaging of dopamine dynamics with designed genetically encoded sensors</article-title><source>Science</source><volume>360</volume><elocation-id>eaat4422</elocation-id><pub-id pub-id-type="doi">10.1126/science.aat4422</pub-id><pub-id pub-id-type="pmid">29853555</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Philippart</surname> <given-names>F</given-names></name><name><surname>Khaliq</surname> <given-names>ZM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>G<sub>i/o</sub> protein-coupled receptors in dopamine neurons inhibit the sodium leak channel NALCN</article-title><source>eLife</source><volume>7</volume><elocation-id>e40984</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.40984</pub-id><pub-id pub-id-type="pmid">30556810</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pissadaki</surname> <given-names>EK</given-names></name><name><surname>Bolam</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>The energy cost of action potential propagation in dopamine neurons: clues to susceptibility in Parkinson's disease</article-title><source>Frontiers in Computational Neuroscience</source><volume>7</volume><elocation-id>13</elocation-id><pub-id pub-id-type="doi">10.3389/fncom.2013.00013</pub-id><pub-id pub-id-type="pmid">23515615</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pitman</surname> <given-names>KA</given-names></name><name><surname>Puil</surname> <given-names>E</given-names></name><name><surname>Borgland</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>GABA(B) modulation of dopamine release in the nucleus accumbens core</article-title><source>The European Journal of Neuroscience</source><volume>40</volume><fpage>3472</fpage><lpage>3480</lpage><pub-id pub-id-type="doi">10.1111/ejn.12733</pub-id><pub-id pub-id-type="pmid">25229321</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Price</surname> <given-names>GD</given-names></name><name><surname>Trussell</surname> <given-names>LO</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Estimate of the chloride concentration in a central glutamatergic terminal: a gramicidin perforated-patch study on the Calyx of held</article-title><source>Journal of Neuroscience</source><volume>26</volume><fpage>11432</fpage><lpage>11436</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.1660-06.2006</pub-id><pub-id pub-id-type="pmid">17079672</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pugh</surname> <given-names>JR</given-names></name><name><surname>Jahr</surname> <given-names>CE</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Axonal GABAA receptors increase cerebellar granule cell excitability and synaptic activity</article-title><source>Journal of Neuroscience</source><volume>31</volume><fpage>565</fpage><lpage>574</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4506-10.2011</pub-id><pub-id pub-id-type="pmid">21228165</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rama</surname> <given-names>S</given-names></name><name><surname>Zbili</surname> <given-names>M</given-names></name><name><surname>Bialowas</surname> <given-names>A</given-names></name><name><surname>Fronzaroli-Molinieres</surname> <given-names>L</given-names></name><name><surname>Ankri</surname> <given-names>N</given-names></name><name><surname>Carlier</surname> <given-names>E</given-names></name><name><surname>Marra</surname> <given-names>V</given-names></name><name><surname>Debanne</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Presynaptic hyperpolarization induces a fast analogue modulation of spike-evoked transmission mediated by axonal sodium channels</article-title><source>Nature Communications</source><volume>6</volume><elocation-id>10163</elocation-id><pub-id pub-id-type="doi">10.1038/ncomms10163</pub-id><pub-id pub-id-type="pmid">26657943</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reimann</surname> <given-names>W</given-names></name><name><surname>Zumstein</surname> <given-names>A</given-names></name><name><surname>Starke</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="1982">1982</year><article-title>Gamma-aminobutyric acid can both inhibit and facilitate dopamine release in the caudate nucleus of the rabbit</article-title><source>Journal of Neurochemistry</source><volume>39</volume><fpage>961</fpage><lpage>969</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.1982.tb11483.x</pub-id><pub-id pub-id-type="pmid">7119795</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname> <given-names>LM</given-names></name><name><surname>Engin</surname> <given-names>E</given-names></name><name><surname>Tantillo</surname> <given-names>G</given-names></name><name><surname>Lau</surname> <given-names>HM</given-names></name><name><surname>Muschamp</surname> <given-names>JW</given-names></name><name><surname>Carlezon</surname> <given-names>WA</given-names></name><name><surname>Rudolph</surname> <given-names>U</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Differential roles of GABA(A) receptor subtypes in benzodiazepine-induced enhancement of brain-stimulation reward</article-title><source>Neuropsychopharmacology</source><volume>37</volume><fpage>2531</fpage><lpage>2540</lpage><pub-id pub-id-type="doi">10.1038/npp.2012.115</pub-id><pub-id pub-id-type="pmid">22763624</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname> <given-names>ME</given-names></name><name><surname>Cragg</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Nicotine amplifies reward-related dopamine signals in striatum</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>583</fpage><lpage>584</lpage><pub-id pub-id-type="doi">10.1038/nn1244</pub-id><pub-id pub-id-type="pmid">15146188</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rinetti-Vargas</surname> <given-names>G</given-names></name><name><surname>Phamluong</surname> <given-names>K</given-names></name><name><surname>Ron</surname> <given-names>D</given-names></name><name><surname>Bender</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Periadolescent maturation of GABAergic hyperpolarization at the axon initial segment</article-title><source>Cell Reports</source><volume>20</volume><fpage>21</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2017.06.030</pub-id><pub-id pub-id-type="pmid">28683314</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowan</surname> <given-names>MJ</given-names></name><name><surname>DelCanto</surname> <given-names>G</given-names></name><name><surname>Yu</surname> <given-names>JJ</given-names></name><name><surname>Kamasawa</surname> <given-names>N</given-names></name><name><surname>Christie</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Synapse-Level determination of action potential duration by K(+) Channel clustering in axons</article-title><source>Neuron</source><volume>91</volume><fpage>370</fpage><lpage>383</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2016.05.035</pub-id><pub-id pub-id-type="pmid">27346528</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ruiz</surname> <given-names>A</given-names></name><name><surname>Campanac</surname> <given-names>E</given-names></name><name><surname>Scott</surname> <given-names>RS</given-names></name><name><surname>Rusakov</surname> <given-names>DA</given-names></name><name><surname>Kullmann</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Presynaptic GABAA receptors enhance transmission and LTP induction at hippocampal mossy fiber synapses</article-title><source>Nature Neuroscience</source><volume>13</volume><fpage>431</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1038/nn.2512</pub-id><pub-id pub-id-type="pmid">20305647</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sabatini</surname> <given-names>BL</given-names></name><name><surname>Regehr</surname> <given-names>WG</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Control of neurotransmitter release by Presynaptic waveform at the granule cell to purkinje cell synapse</article-title><source>The Journal of Neuroscience</source><volume>17</volume><fpage>3425</fpage><lpage>3435</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.17-10-03425.1997</pub-id><pub-id pub-id-type="pmid">9133368</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schelp</surname> <given-names>SA</given-names></name><name><surname>Brodnik</surname> <given-names>ZD</given-names></name><name><surname>Rakowski</surname> <given-names>DR</given-names></name><name><surname>Pultorak</surname> <given-names>KJ</given-names></name><name><surname>Sambells</surname> <given-names>AT</given-names></name><name><surname>España</surname> <given-names>RA</given-names></name><name><surname>Oleson</surname> <given-names>EB</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Diazepam concurrently increases the frequency and decreases the amplitude of transient dopamine release events in the nucleus accumbens</article-title><source>Journal of Pharmacology and Experimental Therapeutics</source><volume>364</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1124/jpet.117.241802</pub-id><pub-id pub-id-type="pmid">29054857</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Semyanov</surname> <given-names>A</given-names></name><name><surname>Walker</surname> <given-names>MC</given-names></name><name><surname>Kullmann</surname> <given-names>DM</given-names></name><name><surname>Silver</surname> <given-names>RA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Tonically active GABA A receptors: modulating gain and maintaining the tone</article-title><source>Trends in Neurosciences</source><volume>27</volume><fpage>262</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2004.03.005</pub-id><pub-id pub-id-type="pmid">15111008</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shin</surname> <given-names>JH</given-names></name><name><surname>Adrover</surname> <given-names>MF</given-names></name><name><surname>Wess</surname> <given-names>J</given-names></name><name><surname>Alvarez</surname> <given-names>VA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Muscarinic regulation of dopamine and glutamate transmission in the nucleus accumbens</article-title><source>PNAS</source><volume>112</volume><fpage>8124</fpage><lpage>8129</lpage><pub-id pub-id-type="doi">10.1073/pnas.1508846112</pub-id><pub-id pub-id-type="pmid">26080439</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname> <given-names>Y</given-names></name><name><surname>Duque</surname> <given-names>A</given-names></name><name><surname>Yu</surname> <given-names>Y</given-names></name><name><surname>Haider</surname> <given-names>B</given-names></name><name><surname>McCormick</surname> <given-names>DA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>Properties of action-potential initiation in neocortical pyramidal cells: evidence from whole cell axon recordings</article-title><source>Journal of Neurophysiology</source><volume>97</volume><fpage>746</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1152/jn.00922.2006</pub-id><pub-id pub-id-type="pmid">17093120</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sidló</surname> <given-names>Z</given-names></name><name><surname>Reggio</surname> <given-names>PH</given-names></name><name><surname>Rice</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Inhibition of striatal dopamine release by CB1 receptor activation requires nonsynaptic communication involving GABA, H2O2, and KATP channels</article-title><source>Neurochemistry International</source><volume>52</volume><fpage>80</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.neuint.2007.07.014</pub-id><pub-id pub-id-type="pmid">17767979</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smolders</surname> <given-names>I</given-names></name><name><surname>De Klippel</surname> <given-names>N</given-names></name><name><surname>Sarre</surname> <given-names>S</given-names></name><name><surname>Ebinger</surname> <given-names>G</given-names></name><name><surname>Michotte</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="1995">1995</year><article-title>Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat</article-title><source>European Journal of Pharmacology</source><volume>284</volume><fpage>83</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1016/0014-2999(95)00369-V</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Starr</surname> <given-names>MS</given-names></name></person-group><year iso-8601-date="1978">1978</year><article-title>GABA potentiates potassium-stimulated 3H-dopamine release from slices of rat substantia nigra and corpus striatum</article-title><source>European Journal of Pharmacology</source><volume>48</volume><fpage>325</fpage><lpage>328</lpage><pub-id pub-id-type="doi">10.1016/0014-2999(78)90091-2</pub-id><pub-id pub-id-type="pmid">639860</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stell</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Biphasic action of axonal GABA-A receptors on presynaptic calcium influx</article-title><source>Journal of Neurophysiology</source><volume>105</volume><fpage>2931</fpage><lpage>2936</lpage><pub-id pub-id-type="doi">10.1152/jn.01125.2010</pub-id><pub-id pub-id-type="pmid">21471393</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulzer</surname> <given-names>D</given-names></name><name><surname>Cragg</surname> <given-names>SJ</given-names></name><name><surname>Rice</surname> <given-names>ME</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Striatal dopamine neurotransmission: regulation of release and uptake</article-title><source>Basal Ganglia</source><volume>6</volume><fpage>123</fpage><lpage>148</lpage><pub-id pub-id-type="doi">10.1016/j.baga.2016.02.001</pub-id><pub-id pub-id-type="pmid">27141430</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Susaki</surname> <given-names>EA</given-names></name><name><surname>Tainaka</surname> <given-names>K</given-names></name><name><surname>Perrin</surname> <given-names>D</given-names></name><name><surname>Yukinaga</surname> <given-names>H</given-names></name><name><surname>Kuno</surname> <given-names>A</given-names></name><name><surname>Ueda</surname> <given-names>HR</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Advanced CUBIC protocols for whole-brain and whole-body clearing and imaging</article-title><source>Nature Protocols</source><volume>10</volume><fpage>1709</fpage><lpage>1727</lpage><pub-id pub-id-type="doi">10.1038/nprot.2015.085</pub-id><pub-id pub-id-type="pmid">26448360</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szabadics</surname> <given-names>J</given-names></name><name><surname>Varga</surname> <given-names>C</given-names></name><name><surname>Molnár</surname> <given-names>G</given-names></name><name><surname>Oláh</surname> <given-names>S</given-names></name><name><surname>Barzó</surname> <given-names>P</given-names></name><name><surname>Tamás</surname> <given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Excitatory effect of GABAergic axo-axonic cells in cortical microcircuits</article-title><source>Science</source><volume>311</volume><fpage>233</fpage><lpage>235</lpage><pub-id pub-id-type="doi">10.1126/science.1121325</pub-id><pub-id pub-id-type="pmid">16410524</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>KR</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name><name><surname>Labouèbe</surname> <given-names>G</given-names></name><name><surname>Yvon</surname> <given-names>C</given-names></name><name><surname>Creton</surname> <given-names>C</given-names></name><name><surname>Fritschy</surname> <given-names>JM</given-names></name><name><surname>Rudolph</surname> <given-names>U</given-names></name><name><surname>Lüscher</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Neural bases for addictive properties of benzodiazepines</article-title><source>Nature</source><volume>463</volume><fpage>769</fpage><lpage>774</lpage><pub-id pub-id-type="doi">10.1038/nature08758</pub-id><pub-id pub-id-type="pmid">20148031</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname> <given-names>KR</given-names></name><name><surname>Rudolph</surname> <given-names>U</given-names></name><name><surname>Lüscher</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hooked on benzodiazepines: gabaa receptor subtypes and addiction</article-title><source>Trends in Neurosciences</source><volume>34</volume><fpage>188</fpage><lpage>197</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2011.01.004</pub-id><pub-id pub-id-type="pmid">21353710</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Threlfell</surname> <given-names>S</given-names></name><name><surname>Lalic</surname> <given-names>T</given-names></name><name><surname>Platt</surname> <given-names>NJ</given-names></name><name><surname>Jennings</surname> <given-names>KA</given-names></name><name><surname>Deisseroth</surname> <given-names>K</given-names></name><name><surname>Cragg</surname> <given-names>SJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons</article-title><source>Neuron</source><volume>75</volume><fpage>58</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.neuron.2012.04.038</pub-id><pub-id pub-id-type="pmid">22794260</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trigo</surname> <given-names>FF</given-names></name><name><surname>Marty</surname> <given-names>A</given-names></name><name><surname>Stell</surname> <given-names>BM</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Axonal GABAA receptors</article-title><source>The European Journal of Neuroscience</source><volume>28</volume><fpage>841</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06404.x</pub-id><pub-id pub-id-type="pmid">18691324</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ungless</surname> <given-names>MA</given-names></name><name><surname>Grace</surname> <given-names>AA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Are you or aren't you? challenges associated with physiologically identifying dopamine neurons</article-title><source>Trends in Neurosciences</source><volume>35</volume><fpage>422</fpage><lpage>430</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2012.02.003</pub-id><pub-id pub-id-type="pmid">22459161</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wójtowicz</surname> <given-names>AM</given-names></name><name><surname>Dvorzhak</surname> <given-names>A</given-names></name><name><surname>Semtner</surname> <given-names>M</given-names></name><name><surname>Grantyn</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Reduced tonic inhibition in striatal output neurons from Huntington mice due to loss of astrocytic GABA release through GAT-3</article-title><source>Frontiers in Neural Circuits</source><volume>7</volume><elocation-id>188</elocation-id><pub-id pub-id-type="doi">10.3389/fncir.2013.00188</pub-id><pub-id pub-id-type="pmid">24324407</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xia</surname> <given-names>Y</given-names></name><name><surname>Zhao</surname> <given-names>Y</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Zeng</surname> <given-names>S</given-names></name><name><surname>Shu</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Regulation of action potential waveforms by axonal GABAA receptors in cortical pyramidal neurons</article-title><source>PLOS ONE</source><volume>9</volume><elocation-id>e100968</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0100968</pub-id><pub-id pub-id-type="pmid">24971996</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="web"><person-group person-group-type="author"><name><surname>Xu-Friedman</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Xu-Friedman lab</article-title><ext-link ext-link-type="uri" xlink:href="https://www.xufriedman.org/mafpc">https://www.xufriedman.org/mafpc</ext-link><date-in-citation iso-8601-date="2019-06-03">June 3, 2019</date-in-citation></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>Z</given-names></name><name><surname>Surmeier</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>D5 dopamine receptors enhance Zn2+-sensitive GABA(A) currents in striatal cholinergic interneurons through a PKA/PP1 cascade</article-title><source>Neuron</source><volume>19</volume><fpage>1115</fpage><lpage>1126</lpage><pub-id pub-id-type="doi">10.1016/S0896-6273(00)80402-X</pub-id><pub-id pub-id-type="pmid">9390524</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>SJ</given-names></name><name><surname>Jackson</surname> <given-names>MB</given-names></name></person-group><year iso-8601-date="1993">1993</year><article-title>GABA-activated chloride channels in secretory nerve endings</article-title><source>Science</source><volume>259</volume><fpage>531</fpage><lpage>534</lpage><pub-id pub-id-type="doi">10.1126/science.8380942</pub-id><pub-id pub-id-type="pmid">8380942</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Sulzer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Glutamate spillover in the striatum depresses dopaminergic transmission by activating group I metabotropic glutamate receptors</article-title><source>The Journal of Neuroscience</source><volume>23</volume><fpage>10585</fpage><lpage>10592</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.23-33-10585.2003</pub-id><pub-id pub-id-type="pmid">14627643</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Sulzer</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Frequency-dependent modulation of dopamine release by nicotine</article-title><source>Nature Neuroscience</source><volume>7</volume><fpage>581</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1038/nn1243</pub-id><pub-id pub-id-type="pmid">15146187</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorrilla de San Martin</surname> <given-names>J</given-names></name><name><surname>Trigo</surname> <given-names>FF</given-names></name><name><surname>Kawaguchi</surname> <given-names>SY</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Axonal GAB<sub>AA</sub> receptors depolarize presynaptic terminals and facilitate transmitter release in cerebellar Purkinje cells</article-title><source>The Journal of Physiology</source><volume>595</volume><fpage>7477</fpage><lpage>7493</lpage><pub-id pub-id-type="doi">10.1113/JP275369</pub-id><pub-id pub-id-type="pmid">29072780</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.55729.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Overstreet-Wadiche</surname><given-names>Linda</given-names></name><role>Reviewing Editor</role><aff><institution>University of Alabama at Birmingham</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Ford</surname><given-names>Christopher</given-names> </name><role>Reviewer</role><aff><institution>University of Colorado Anschutz Medical Campus</institution><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>Axonal receptors on dopamine neurons allow local regulation of dopamine release at a distance from the cell body. The authors here use elegant electrophysiological and imaging approaches to show that GABAA receptors depolarize distal dopaminergic axons to reduce axonal excitability, providing new understanding of how GABA inhibits dopamine release in the striatum.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Axonal mechanisms mediating GABA-A receptor inhibition of striatal dopamine release&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by John Huguenard as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Christopher Ford (Reviewer #2).</p><p>The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.</p><p>Summary:</p><p>Here the authors examine how GABAA receptors expressed on the axons of dopamine neurons inhibit release of dopamine, providing a mechanistic explanation for prior findings that GABA inhibits DA release in the striatum. Through a series of technically challenging electrophysiological and imaging experiments, the authors conclude that axonal GABAA receptors depolarize axons to reduce action potential propagation (spike height) via a combination of shunting and inactivation of sodium channels. They also conclude that the benzodiazepine diazepam acts on the endogenous tone of GABA present in the striatum to decrease DA release via shunting inhibition. Overall the conclusions are convincing and provide new insight into regulation of DA release as well as general mechanisms of axonal modulation by presynaptic receptors.</p><p>Essential revisions:</p><p>1) While the results are convincing that axonal GABAA receptors are present and can modulate axonal excitability, it is less clear that there is a tonic GABAA-mediated current due to ambient GABA in the slice. Analysis of effects of GABAA receptor antagonists alone should be expanded to illustrate the actions on endogenous GABA (i.e. as in Figures 3, 4 or 5). Currently the strongest data supporting endogenous GABAA receptor activation (Figure 5A) is complicated by co-application of CGP55845, which is an inverse agonist at GABAB receptors that are generally higher affinity than GABAA receptors. It is possible that ambient GABA is too low to significantly activate GABAA receptors but diazepam enables activation by increasing GABAA receptor affinity.</p><p>2) The authors suggest reliability of spike propagation in the highly branched distal axon may be reduced by GABA (subsection “Stronger effect of GABA-A inhibition on APs that undergo propagation”), but the calcium imaging results do not really support this conclusion (Figure 3D-F). There are a number of explanations that could account for the greater decrease in calcium signal in the distal axon, the simplest being that GABAAR expression increases in the distal axon (or Ecl is more depolarized). Also, the authors report a decrease in spike amplitude (Figure 4), but do not mention seeing greater spike failures when applying GABA, suggesting branch point failures are not common. Other mechanisms should be considered and discussed.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.55729.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) While the results are convincing that axonal GABAA receptors are present and can modulate axonal excitability, it is less clear that there is a tonic GABAA-mediated current due to ambient GABA in the slice. Analysis of effects of GABAA receptor antagonists alone should be expanded to illustrate the actions on endogenous GABA (i.e. as in Figures 3, 4 or 5). Currently the strongest data supporting endogenous GABAA receptor activation (Figure 5A) is complicated by co-application of CGP55845, which is an inverse agonist at GABAB receptors that are generally higher affinity than GABAA receptors. It is possible that ambient GABA is too low to significantly activate GABAA receptors but diazepam enables activation by increasing GABAA receptor affinity.</p></disp-quote><p>This reviewer comment raises the question of whether tonic GABA is present in the slice. We will first respond to this by stating that our experiments testing direct axonal input resistance argue strongly for the presence of tonic GABA. In particular, we found that application of diazepam in the absence of any exogenously applied GABA application or synaptic stimulation resulted in a clear decrease in the input resistance of dopaminergic neuron axons in the striatum. The effect of diazepam on axonal input resistance was reversed by GABA-A receptor antagonists suggesting that the effect is not due to off-target effects but rather is specific to GABA-A receptors. In addition, we found that diazepam had no effect on the main axon demonstrating that tonic GABA-A mediated current is confined to dopaminergic neuron axons in striatum. Together, we believe that these experiments demonstrate that diazepam directly inhibits dopamine and provides strong evidence for the presence of tonic GABA in the striatum.</p><p>As suggested by the reviewers, it is unclear whether the tonic level of GABA-A receptor activity in striatum is strong enough to inhibit dopamine release in the absence of GABA-A positive modulators. To address this question, we performed new imaging experiments. We tested the effect of the GABA-A antagonist, gabazine, on stimulated dopamine release using dLight and found that gabazine alone does not significantly increase dopamine release. Therefore, although the concentration of tonic GABA is sufficient to inhibit dopamine release through activation of GABA-B receptors (Figure 6—figure supplement 1A, B), it is not sufficient to measurably inhibit dopamine release through GABA-A receptors under control conditions (i.e. in the absence of benzodiazepines). These new experimental data have been included in Figure 6—figure supplement 1C, D and a description of this experiment has been added to the subsection “Benzodiazepines enhance tonic GABA activity on dopamine neuron axons” of the Results section. It is important to note that our experiments were performed in deafferented brain slices that lack ongoing firing activity. However, in vivo experiments in other brain regions such as cerebellum have observed tonic GABA-A mediated inhibitory currents which significantly dampen action potential firing activity of granule neurons (Chadderton et al., 2004). Likewise, striatal neurons are also more active under in vivo conditions and in behaving animals. Therefore, future work should examine whether tonic GABA-A mediated currents play a role in controlling striatal dopamine release under these conditions.</p><disp-quote content-type="editor-comment"><p>2) The authors suggest reliability of spike propagation in the highly branched distal axon may be reduced by GABA (subsection “Stronger effect of GABA-A inhibition on APs that undergo propagation”), but the calcium imaging results do not really support this conclusion (Figure 3D-F). There are a number of explanations that could account for the greater decrease in calcium signal in the distal axon, the simplest being that GABAAR expression increases in the distal axon (or Ecl is more depolarized).</p></disp-quote><p>The reviewers raised the point that the greater decrease in axonal calcium signals by muscimol observed in the rostral striatum (Figure 5A-C) may be due to regional differences in inhibitory axonal signaling such as stronger GABA-A expression levels and/or more depolarized chloride reversal potentials. To examine this possibility, we tested the effect of muscimol on axonal calcium signals that were both stimulated and imaged within the rostral striatum. Similar to analogous experiments performed in the caudal striatum (Figure 5D-F), we observed little effect of muscimol on axonal calcium signals that were both stimulated and imaged locally within rostral striatum (Figure 5G-I). Therefore, these new data demonstrate that muscimol has little effect on axonal calcium signals that result from local stimulation of either caudal or rostral striatum.</p><p>By contrast, GABA-A receptor activation results in substantial inhibition of axonal calcium signals imaged in rostral striatum when those signals were generated by distal stimulation of the caudal striatum. These observations demonstrate that calcium signals in axons of dopaminergic neurons within the striatum are most greatly affected by GABA-A receptor activation under conditions involving spike propagation over large distances.</p><disp-quote content-type="editor-comment"><p>Also, the authors report a decrease in spike amplitude (Figure 4), but do not mention seeing greater spike failures when applying GABA, suggesting branch point failures are not common. Other mechanisms should be considered and discussed.</p></disp-quote><p>To clarify this point, the experiments described in Figure 4 test the effects of GABA-A receptor activation on action potentials recorded in the main axon trunk (i.e. before the axon has branched). Secondly, the GABA puffer pipette was typically placed very closely to the recording site which means that propagation occurred only over very short distances in these experiments. Although we do not observe clear failures under these experimental conditions, however, we believe that the decrease in spike amplitude following GABA application to unbranching main axons shown in Figure 4 is likely also a key contributor to the inhibition of calcium signals in branching striatal axons tested in Figure 5A-C.</p><p>Although we believe that propagation is important condition for the results shown in Figure 4, we agree that branch point failure is not the only mechanism and have edited our manuscript to clarify this point. In particular, we hypothesize that as action potentials propagate throughout the axon, the effect of GABA-A receptors in shortening the amplitude of spikes becomes progressively greater with distance. The shorter amplitude spikes will likely reduce calcium influx and inhibit dopamine release. In addition, we hypothesize that in some cases these shorter spikes would eventually lead to an increase in branch point failures. Future experiments should seek to use whole-cell axonal recordings to directly measure action potential waveforms in the striatal axon following GABA-A activation. Discussion of this topic has been added to the main text (subsection “Mechanism of axonal GABA-A receptor mediated inhibition of striatal dopamine release”).</p></body></sub-article></article>